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The Effect of Actin Reorganization in Insulin Mediated Glucose 
Transport on L6 Rat Skeletal Muscle Cells 
Abstract 
Maintaining of glucose homeostasis is vital to human life. The human brain, which 
serves as the central processing unit of the body, utilizes glucose as the primary metabolic 
fuel. Since the brain cannot store or synthesize glucose, glucose is derived from the 
circulation continuously. Thus, the prevention or rapid correction of hypoglycemia is 
critical to our survival. However, sustained hyperglycemia can cause severe tissue 
damage and lead to diabetic complications such as blindness, renal failure, cardiac and 
peripheral vascular diseases, neuropathy and sexual dysfunction. As a result, by 
achieving a balance between the glucose utilization and the sum of endogenous glucose 
production and dietary glucose intake, blood glucose level can be maintained in a 
physiological range. 
One of the key factors in regulating glucose utilization is the stimulation of glucose 
uptake into muscles by insulin. Skeletal muscle is the primary site of insulin-mediated 
glucose uptake. Since the lipid bilayers that make up the cell membranes are 
impermeable to glucose, facilitated glucose transport down the concentration gradient 
across the cell membranes relies on transmembrane proteins - Glucose transporters 
(GLUT). In muscle, GLUT4 are the major insulin-responsive GLUT. Upon the action 
of insulin, translocations of GLUT4 from intracellular compartments to the plasma 
membrane (PM) are enhanced. The net effect is an increase of glucose transport into the 
cells. This enhancement is facilitated by the reorganization of cortical actin filaments 
ix 
that localizes insulin downstream signaling intermediates to the GLUT-containing 
compartments. Proper interactions are essential to the regulation of glucose 
homeostasis. 
Insulin resistance, the ineffectiveness of insulin to stimulate glucose uptake, is a major 
characteristics of Type II Diabetes Mellitus (DM) and obesity. Although insulin 
resistance is well characterized, the exact mechanism remains unclear. Patients with 
diabetes are normally hyperglycemia and hyperinsulinemia. Higher plasma free fatty 
acid (FFA) and total serum cholesterol levels are also common in diabetics. In the 
present study, we have examined the role of the actin reorganization in the stimulation of 
glucose uptake and the distribution of GLUT4 in L6 myotubes expressing myc-tagged 
GLUT4 (GLUT4myc). The study was divided into three parts: (1) the effect of insulin 
and glucose; (2) the effect of FFA; (3) the effect of cholesterol. Cells were incubated in 
various concentrations of insulin (up to lOOnM) and glucose (up to 25mM), FFA (up to 
75^M) or cholesterol (up to 60|iM) for 24 hours and stimulated with insulin (lOOnM, 30 
min for glucose uptake and lOOnM, 10 min for actin remodeling). Glucose uptakes 
were assessed with 2-deoxy-D-[^H] glucose and actin remodeling was examined by 
immunofluorescence microscopy (IM) and transmission electron microscopy (TEM). 
Results from present study showed that preincubation with high glucose (25mM) and 
high insulin (lOOnM) levels reduced glucose uptake by 74.4 土 10.9%，(p 二 0.00001). 
Secondly, high levels of unsaturated fatty acids preincubation (50|iM) - oleic acid (OA) 
and linoleic acid (LA) for 24 hours diminished glucose uptake by 45.8 土 8.6%, (p = 
xii 
I 
0.0005) and 57.1 土 8.5%，（p = 0.004) respectively. Meanwhile, exposure of saturated 
fatty acid (50^M) - palmitic acid (PA) caused a 33.3 土 8.8%, (p = 0.0008) reduction in 
glucose uptake. Finally, high cholesterol (CHO) preincubation (50|aM) caused a 56.7 土 
8.5%, (p = 0.0005) reduction in glucose uptake. 
IM was carried out to examine the morphological changes of cortical actin. We 
visualize cortical actin and GLUT4myc by double staining of permeabilized cells with 
labeled phalloidin and a monoclonal antibody to the myc epitope. Under the basal state, 
actin bundles were aligned longitudinally along the cells while GLUT4myc were 
concentrated around the myonuclei. The lO-minute insulin stimulation caused actin 
filament reorganization as membrane ruffles throughout the cells. Meanwhile, 
GLUT4myc colocalized with these actin structures. Preincubation with high glucose 
(25mM) and high insulin (lOOnM) levels reduced actin remodeling by 64.7%, (p < 0.001). 
In addition, high levels of OA, LA and PA preincubation (50|iM) for 24 hours diminished 
actin remodeling by 46.2%, (p < 0.005)，51.0%, (p < 0.0005)，and 37.6%, (p < 0.0001) 
respectively. Finally, high cholesterol (50|iM) preincubation caused a 53.0%, (p < 
0.0005) reduction in actin remodeling. 
Moreover, we have conducted an IM study in membrane-intact cells. Cell surface 
immunostaining was carried out for both actin and GLUT4myc. In the basal state, actin 
structures were distributed along the surface while GLUT4myc were barely visible. 
After the lO-minute insulin treatment, colocalization of actin and GLUT4myc were 
observed. L6 myotubes were then incubated in insulin (lOOnM) and glucose (25mM), 
xi 
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FFA (50|iM) or cholesterol (50|iM) for 24 hours and stimulated with insulin (lOOnM, 10 
min). By comparing with their respective controls, there were reductions in 
insulin-induced recruitment of GLUT4myc. 
In order to have a more accurate picture of insulin-mediated glucose uptake, we 
performed TEM in our study. We identified cortical actin and GLUT4myc with 
immunogold labeling. The lO-minute insulin stimulation reconfirmed the GLUT4myc 
colocalization with actin structures. Additionally, the preincubation experiments also 
reduced the degree of GLUT4myc colocalization with actin. 
In conclusion, both IM and TEM studies showed a clear spatial relationship between 
actin networks and GLUT4 during the course of insulin-mediated glucose uptake in 
muscle cells. Their colocalization is vital to the success of glucose transport. Patients 
with diabetes are normally have elevated levels of glucose, insulin, FFA and total serum 
cholesterol. The preincubation experiments resulted in dose-dependent reductions in 
glucose uptake. In addition, there were also parallel dose-dependent reductions in the 
actin reorganization. Therefore, disassembly of the actin network may play a role in 
glucose transport reduction, which may in turn allow us to have a better understanding of 





























了百分之74.4 ±10.9的葡萄糖攝取，（P ： 0 .00001)�其次’與24小時不飽和脂肪酸一起培養 
下：油酸和亞麻油酸（50微摩爾）分別減少了達百分之45.8 ± 8.6，(P = 0.0005 )和百分之 
57.1 ± 8.5，(P = 0.004)葡萄糖攝取。同時’與24小時飽和脂肪酸一起培養下’棕櫚酸（50 
微摩爾)減少了葡萄糖攝取百分之33.3 ± 8.8，（P 二 0.0008)�最後’與高膽固醇一起培養（50 
微摩爾）葡萄糖的攝取減少了百分之56.7 ± 8.5 ’ (P - 0.0005)� 
我們利用免疫蛋光顯微鏡方法檢查皮層肌動蛋白形態的變化。我們用抗體來顯現皮層肌動蛋 




胰島素（100毫微摩爾）濃度的培養減少百分之64.7， ( P<0.001)的肌動蛋白重組。此外， 
24小時高濃度油酸，亞麻油酸和棕櫚酸的培養（50微摩爾）分別減少了百分之46.2，（P < 
0 . 0 0 5 )， 5 1 . 0 ‘ (P < 0 . 0 0 0 5 ) ，和 37.6, (p < 0 . 0 0 0 1 )的肌動蛋白重組。最後，高 
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CHAPTER ONE INTRODUCTION 
1.1 Glucose Homeostasis 
Glucose is a small and polar monosaccharide. However, its physiological 
significance to our bodies is indispensable. Since abnormalities in glucose 
homeostasis threaten our survivals, blood glucose level is maintained within a narrow 
range despite the wide variations in activities and food intake. There is a collective 
effort by a controlled balance of hormonal, neural and substrate glucoregulation. 
One of the pivotal glucoregulatory components is the insulin-mediated glucose uptake 
in skeletal muscle. The transportation of glucose across the PM is dependent on the 
functioning of GLUT. Hence, aberrant GLUT action may disrupt glucose transport 
and affect normal glucose homeostasis. 
1.1.1 Function 
Glucose is in essential for life. First of all, glucose serves as metabolic fuel. For 
example, the brain and skeletal cells utilize glucose for the production of adenosine 
triphosphate (ATP) which is required for various cellular activities. In fact, glucose 
1 
is the primary fuel for brain. Inadequate supply of glucose can cause severe neural 
dysfunction. Secondly, glucose is converted to glycogen through the action of 
enzyme glycogen synthase {Halse, Bonavaud, et al. 2001}. The exchange between 
glucose and glycogen allows cells to build up glucose storage for future use. It 
provides a reserve pool by which tissues can interact with the surrounding and alter 
physiological glucose concentration. Thirdly, glucose can act as the precursor for 
FFA, protein and cholesterol production. The extensive interaction among glucose, 
EFA, protein and cholesterol metabolism allows the body to maximize the use of 
existing resources {Cryer 1997}. 
1.1.2 Origins and regulation of glucose 
Glucose is derived from three sources: dietary intake of carbohydrates; endogenous 
production by gluconeogenesis; and glycogen breakdown by glycogenolysis. The 
digestion of carbohydrates takes place along the gastrointestinal tract. Glucose is 
actively taken up into the cells by sodium-linked GLUT in the intestinal lumen. 
These transporters actively transport glucose against a glucose-concentration gradient 
using the energy provided from the electrochemical potential difference of sodium 
ions across the PM {Kahn 1992}. Once it enters the target tissues through the 
2 
circulation, glucose is rapidly phosphorylated to gIucose-6-phospahte (G-6-P). 
Intracellular G-6-P can be metabolized through glycolysis, stored as glycogen or 
converted back to glucose if suitable enzymes and precursors are available. Through 
the process of glycolysis, G-6-P is converted to pyruvate and ATP is also generated. 
Pyruvate can be further reduced to lactate, transaminated to form alanine, or 
converted to acetyl coenzyme and generate more ATP via the Krebs cycle {Cryer 
1997}. 
Endogenous glucose production relies on gluconeogenesis and glycogenolysis. 
Gluconeogenesis can be viewed as the reversal of glycolysis. It involves the 
formation of glucose from precursors such as lactate, glycerol, and amino acids. 
Glycogenolysis involves the breakdown of glycogen to G-6-P with its subsequent 
hydrolysis to free glucose. Both the liver and kidney contain the enzymes required 
for gluconeogenesis and glycogenolysis while muscle contains only the enzymes for 
glycogenolysis {Cryer 1997}. 
Maintenance of the normal blood glucose concentration requires a precise matching 
of endogenous glucose availability and glucose utilization. The metabolic shift of 
glucose depends on the current body nutritional status. During the fasting phase, 
3 
peripheral glucose utilization is reduced while gluconeogenesis and glycogenolysis 
are enhanced. The body compensates the lack of glucose by switching to other 
possible metabolic fuels such as ketone body or FFA. In the fed state, elevated 
glucose concentration promotes the utilization of glucose, reduction of endogenous 
glucose production and increased formation of glycogen, fat and protein {Frier & 
Fisher 1999}. 
1.1.3 Glucoregulatory factors 
Glucose homeostasis requires close interactions between different hormones, 
neurotransmitters and substrate. Hormones are the most important glucoregulatory 
factors and their secretions are normally guided by plasma glucose concentration. 
Glucoregulatory hormones are divided into two groups: insulin and counterregulatory 
hormones including glucagons, epinephrine, growth hormone, and Cortisol. Insulin 
is a glucose-lowering hormone that suppresses endogenous glucose production and 
enhances glucose utilization. It acts on liver, kidney and peripheral tissues. It 
suppresses hepatic glycogenolysis and gluconeogenesis, and promotes hepatic 
glycogen storage. Besides, it also stimulates glucose uptake and utilization in 
muscle and fat cells. The net result of insulin action is to reduce plasma glucose 
4 
level by enhancing its metabolic use and storage. On the other hand, suppressing 
insulin secretion causes the reverse effect by increasing glucose production and 
decreasing glucose utilization {Wilson 1998}. As a result, by controlling the insulin 
secretion, the blood glucose level can be adjusted according to the physiological need. 
The counterregulatory hormones include glucagons, epinephrine, growth hormone, 
and Cortisol. In response of hypoglycemia they are secreted into the circulation to 
raise the glucose level. For instance, glucagon is secreted from pancreatic a cells. 
It activates hepatic glycogenolysis and gluconeogenesis to promote glucose 
production. Moreover, epinephrine suppresses insulin secretion and therefore 
increases blood glucose levels. It also activates hepatic glycogenolysis and 
gluconeogenesis, and limits glucose utilization in muscle and fat cells. Furthermore, 
long-term elevations of growth hormone and Cortisol reduce glucose utilization and 
stimulate glucose production {Wilson 1998}. Different types of counterregulatory 
hormones work together and produce the glucose-raising effect. 
The neural glucoregulatory factor includes norepinephrine, a neurotransmitter 
released from terminals of sympathetic postganglionic neurons. Sympathetic 
stimulation through the hepatic sympathetic nerves suppresses glycogen formation 
5 
and enhances glucose release. On the other hand, parasympathetic stimulation 
increases glycogen formation and reduces glucose release. As a result, like insulin， 
the neural glucoregulatory factor can regulate the glucose level in both directions 
{Wilson 1998}. 
The substrate glucoregulatory factors include glucose and fatty acid. Glucose acts as 
a feedback signal that induces glucose storage and reduces glucose production. In 
addition, fatty acid promotes glucose production and limit glucose oxidation probably 
through the glucose-fatty acid cycle {Boden，Chen, et al. 1994}. 
1.1.4 Insulin 
Since the discovery of insulin in the early 1920s, elucidating insulin intracellular 
signaling pathway and its action on target cells has been the primary focus for a large 
number of investigators for decades. We will put our main focus on the ability of 
insulin to stimulate glucose uptake since it is more relevant to the clinical symptoms 
of DM. Defining the insulin signaling mechanism could lead to a better 
understanding of insulin resistance associated with obesity and Type 2 diabetes. 
6 
1.1.4.1 Function of Insulin 
Insulin is an anabolic hormone with powerful metabolic and mitogenic effects. 
Insulin exerts its effect predominately on three main target tissues: liver, fat and 
skeletal muscle cells. Insulin regulates a variety of metabolic and mitogenic effects 
in target tissues, including stimulation of glucose transport and glycogen synthesis, 
inhibition of hepatic gluconeogenesis and glycogenolysis, stimulation of lipogenesis, 
gene transcription and translation, and cell replication {Pessin & Saltiel 2000}. 
1.1.4.2 Discovery and Production of Insulin 
The road of insulin discovery started in Toronto. In the early 1920s, Banting, Best 
and Macleod began the work by succeeded in preparing extracts of pancreas that had ‘ j 
i ) 
a potential to lower blood glucose level in patients with diabetes. This discovery 
leaded to the crystallization of insulin and its eventual identification as a peptide 
hormone. Methods for the preparation of insulin from animal pancreas were 
developed by commercial firms, which became available for both the treatment of 
DM and the study of protein biochemistry {Bliss 1987}. 
7 
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The P cells of the pancreatic islets are responsible for insulin production. The 
removal of a 23-amino-acid leader sequence from the preproinsulin produces 
proinsulin. Proinsulin is then converted to insulin and C-peptide through the action 
of endoproteases in secretary vesicles {Hunter & Garvey 1998}. With the aid of 
the cytoskeleton, secretary vesicles fuse with the PM of |3 cell and release their 
contents to the circulation. 
The secretion of insulin is determined by many regulatory factors. For example, 
protein kinase C (PKC) in insulin signaling pathway has been identified in the 
pancreatic islet to stimulate insulin secretion. Besides, glucagons, glucose and 
amino acid have also been found to enhance the secretion. On the other hand, 
somatostatin has been reported to inhibit insulin secretion {Leslie & Robbins 1995} 
1.1.4.3 Insulin Signaling Pathway 
1.1.4.3.1 Insulin Receptor 
The insulin intracellular signaling pathway (fig. 1) is initiated with the specific 
binding of insulin to insulin receptor (IR) on the PM of target cells. The IR consists 
8 
Fig.l Metabolic and mitogenic signaling pathway in insulin action IR = 
insulin receptor; IRS = IR substrate; She = Src and Collagen Homologous; mSos 
=mammalian Son of Sevenless; MAPK = Mitogen-Activated Protein Kinase; 
PI3-K = Phosphatidylinositol 3-Kinase; PIP2 = Phosphatidylinositol 4， 
5-bisphosphate; PIP3 = Phosphatidylinositol 3，4，5-triphosphate; PDK = 















































































































































of two a and two P subunits that are disulfide linked into a a2p2 tetrameric complex 
{Pessin & Saltiel 2000}. The a-subunit is located entirely at the extracellular face of 
the PM and contains the insulin-binding site while the P-subunit is a transmembrane 
peptide. The binding of insulin to the a-subunit activates the tyrosine kinase and 
leads to autophosphorylation of tyrosine residues of P-subunit. Once activated, the 
IR phosphorylates a number of important proximal substrates on tyrosine. 
Molecules with phosphate-tyrosine binding domains or with Src homology 2 (SH2) 
domains are targets for IR phosphorylation. IR substrate (IRS) and Src and collagen 
homologous (She) engage the IR directly and serve as docking sites for downstream 
signaling substrates {Le Roith & Zick 2001}. 
1.1.4.3.2 MAPK Pathway 
Divergence of insulin signaling pathways occurs at the level of IRS and She docking 
proteins. The binding of Grb-2 adaptor protein with IRS or She via their SH2 
domains triggers mitogen-activated protein kinase (MAPK) pathway. Grb-2 then 
binds with the mammalian Son of Sevenless (mSos), a nucleotide exchange protein 
that catalyzes the exchange of guanosine diphosphate (GDP) for guanosine 
triphosphate (GTP) on Ras. The GTP bound Ras activates Raf kinase and initiates a 
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cascade of phosphorylations leading to the activation of MAPK kinase, MAPK and 
pp90 S6 kinase {Hunter & Garvey 1998}. In addition, activated forms of Ras also 
activate Rac, which in turn induces membrane ruffles {Tsakiridis, Tong, et al. 1999}. 
The MAPK pathway mediates the mitogenic and growth-promoting effects of insulin 
by phosphorylating transcription factors, leading to the induction of gene. 
1.1.4.3.3 Phosphatidylinositol 3-kinase (PI3-K) Pathway 
The activation of PI3-K pathway is initiated from the phosphorylation of IRS. PI3-K, 
a lipid kinase consisting of a p85 regulatory subunit and a pi 10 catalytic subunit, 
binds to IRS through the SH2 domains of the p85 subunit. This results in the 
activation of pi 10 subunit to produce phosphatidylinositol 3，4，5-phosphate (PIP3). 
PIP3 binds to PI3-K-dependent kinase (PDK) and leads to the activations of 
downstream kinases including the Akt (also known as protein kinase B), PKC ； and 
PKC X and inactivation of glycogen synthase kinase-3 (GSK-3). The PI3-K pathway 
is mainly responsible for the metabolic actions of insulin including glucose uptake, 
glycogen and protein synthesis. 
The PI3-K pathway is essential for insulin-induced glucose uptake. It activates the 
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translocation of intracellular GLUT4 to the PM and thereby enhances the glucose 
transport across the membrane. Besides, the PI3-K pathway is also mediating the 
glycogen and protein synthesis. GSK-3 mediates the inactivation of glycogen 
synthesis and protein synthesis eukaryotic factor. In response to insulin, activated 
Akt phosphorylates and inactivates GSK-3. This directly results in enhancement in 
glycogen synthesis and protein synthesis. In addition, insulin also activates protein 
synthesis through activation of proteins downstream of Akt in the kinase mammalian 
Target of Rapamycin pathway {Le Roith & Zick 2001}. As a result, successful 
sequentially activations along the insulin-signaling pathway are essential for the 
homeostasis of glucose and protein metabolism. 
1.1.5 Glucose Transporters 
Since the lipid bilayers that make up the cell membranes are impermeable to glucose, 
two families of GLUT are responsible to the transport of glucose across the cell. 
The sodium-linked GLUT is an active transport transporter located in the luminal 
epithelial surface of cells of small intestine and proximal convoluted tubule of the 
kidney. These transporters actively transport glucose against a 
glucose-concentration gradient using the energy provided from the electrochemical 
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potential difference of sodium ions across the PM {Kahn 1992}. 
The second family of GLUT is a facilitative transporter. This type of transporters 
facilitates the diffusion of glucose down the glucose-concentration gradients. Five 
glucose transporters genes have been identified according to their chronological order 
of discovery. Most facilitative transporters are saturable and are mostly specific for 
the transport of D-glucose. GLUTl is present in most tissues，particularly in the PM 
of blood-brain barrier, erythrocyte, placenta, kidney and perineurial sheath of muscle. 
GLUTl is largely a basal transporter and is responsible for transporting glucose 
across the blood-brain barrier; GLUT2 is predominately found in the PM of kidney, 
small intestine, liver and pancreatic beta cell. GLUT2 is insulin independent and 
functions to facilitate rapid glucose equilibrium across the membrane. Its ability of 
glucose exchange is so high that it can cope with a wide range of physiological 
I 
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glucose concentration across the membrane where transport does not become rate 
limiting in GLUT2 predominating tissues {Kahn 1992}. This is especially important 
to liver and kidney as it provides a mechanism to regulate physiological glucose 
levels by shifting between glucose production and glucose utilization; GLUTS is 
mostly found in all tissues but is predominately expressed in brain and placenta. 
GLUTS interacts with GLUTl and is responsible for transporting glucose to neurons 
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{Frier & Fisher 1999}. Once again GLUT3 is a basal transporter and provide cells 
with basic glucose metabolic need; GLUT4 is the major insulin responsive transporter 
that is mostly found in intracellular compartments of adipose cells, cardiac and 
skeletal muscle cells. Upon stimuli such as insulin or exercise, the intracellular 
GLUT4 is recruited to the PM that can produce up to a ten-fold increase in glucose 
transport over the basal rate. The intracellular location of GLUT4 at basal state 
provides a reserve pool by which GLUT4-containing tissues can rapidly modify the 
rate of glucose transport. This transporter can be saturated in vivo. Thus, transport 
can be rate limiting for tissue where GLUT4 is the major glucose transporter; GLUT5 
is a fructose transporter that is located in small intestine, sperm, kidney, brain, adipose 
cells and muscle {Shepherd & Kahn 1999}. 
1.1.6 Role of skeletal muscle in glucose homeostasis 
Skeletal muscle is an important site for glucose utilization. It accounts for 
approximately 70 to 80 % {Jackson, Bagstaff, et al. 2000} or even 85% {DeFronzo, 
Jacot, et al. 1981} of total glucose metabolism. Another study from Meyer et al 
suggested that after a carbohydrate meal, liver took up about 25 to 35% of ingested 
carbohydrate. Of the remaining 65 to 75% that entered the circulation, about 40% 
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would be taken up by skeletal muscle and about 10% by kidney. The brain would 
take up another 15 to 20% of the ingested glucose. Therefore, uptake of glucose by 
liver, kidney, skeletal muscle and brain would be accounted for almost 90% of the 
ingested glucose {Meyer, Dostou, et al. 2002}. Despite there are numbering 
differences between different studies, skeletal muscle is still the predominately site for 
peripheral glucose utilization. Since there is a lack of intracellular free glucose 
accumulation, it is widely believed that glucose transport is the rate-limiting step for 
glucose metabolism in skeletal muscle {Ziel, Venkatesan, et al. 1988}. Thus, normal 
functioning of GLUT4 in skeletal muscle is important to regulate the glucose 
utilization. 
1.1.7 Insulin Resistance 
. i [ 
The concept of insulin resistance arose from the insulin therapy to patients with '' 
* 
diabetes. In the late 1930s, it became evident that patients with diabetes could be 
divided into two groups based on their relative sensitivity to exogenous insulin 
therapy {Moller 1993}. The two patterns of insulin sensitivity correspond to the 
modem classification of Type I and Type II diabetes. The response of insulin 
treatment in patients with Type II diabetes is far less effective than the one from 
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patients with Type I diabetes. Despite the multiple functional roles of insulin, the 
term insulin resistance is generally referred as the ineffectiveness of insulin to 
stimulate glucose uptake. It contributes to clinical symptoms of diabetes: 
hyperglycemia and impaired glucose tolerance. 
In the case of insulin resistance, insulin levels are elevated to compensate for the loss 
of insulin effectiveness. This compensatory insulin secretion is the result of 
expanded p cell mass and altered enzyme expression in pancreas {Cavaghan, 
Ehrmann, et al. 2000}. Evidences for these two correctional mechanisms come from 
studies of Zucker fatty rats，which are obese and become insulin resistant at the later 
stages of their lives. They are found to contain expanded pancreatic P cell mass and 
do not develop DM. In addition, they are also found to have altered activities in two 
glucose-phosphorylating enzymes: glucokinase (GK) and hexokinase (HK). 
Conversion of glucose to G-6-P is normally controlled by GK in pancreatic P cells, ’ 
i 
which is less glucose-sensitive than HK. Insulin resistance causes an increase in HK 
expression. The overexpression of HK allows the pancreatic p cells to induce a 
higher glucose-stimulated insulin release and overall glucose metabolism {Cavaghan, 
Ehrmann, et al. 2000}. Insulin secretion is initially able to compensate for insulin 
resistance to produce a normal glucose tolerance. Thus, insulin resistance may occur 
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for many years before the diagnosis of Type II diabetes is made. However, the p 
cells may be exhausted by the overproduction of insulin or genetic and inherited 
defect. It appeared that the defect is specific for glucose-dependent insulin release 
{Leslie & Robbins 1995}. Once the p cells fail to produce sufficient insulin, 
hyperglycemia occurs and may lead to the development of Type II DM. As a result, 
insulin resistance could be the main cause of DM. Thus, by understanding the nature 
( 
of insulin resistance, it could lead us to a better understanding of the pathology of 
DM. 
1.1.8 Glucose abnormality and its complications 
Glucose abnormality posts a severe threat to our survivals. On one end of the 
spectrum, hypoglycemia predominantly affects the human brain. Normal 
functioning of the brain requires a continuous supply of glucose as its primary 
metabolic fuel. Since the brain cannot synthesize or store glucose, inadequate 
supply of glucose could impair neural metabolism. In addition, glucose can be 
converted into other biochemical compounds such as neurotransmitters. Lack of 
glucose precursors may affect their productions {Frier & F 1993} and influence brain 
function. Taken together, glucose deprivation can cause severe brain dysfunctions 
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and even brain death. 
On the other end of the spectrum, sustained hyperglycemia causes severe tissue 
damage and leads to diabetic complications. The processes of tissue damage involve 
protein glycation, excessive production of polyol compounds from glucose and 
increase in blood flow. First of all, in the presence of high glucose concentration, 
glucose can be incorporated into proteins by unregulated nonenzymatic glycation 
reaction. The glucose incorporation may modify the protein structure and thereby 
impair the protein function. Besides, the glycated proteins also form advanced 
glycation end products (AGEs) that further disrupt and cause additional deleterious 
effects {Wilson 1998}. The second potential cause of tissue damage lies in the 
polyol pathway. Glucose is reduced to sorbitol by aldose reductase and then 
. . I' 
oxidized to fructose by sorbitol dehydrogenase. Increased activation of polyol 
i ) 
pathway inactivates 3-phosphate dehydrogenase that converts glyceraldehydes 丨 
3-phospahte to pyruvate. Excess glyceraldehydes 3-phospahte induce nonenzymatic 
protein glycation. In addition to defected protein structure and function such as in 
the case of basement membrane of blood vessel, there is also an alteration in the 
sensitivity of intracellular receptor, which stimulates tissue thickening in the 
endothelial surface through the release of cytokines and growth factors. Besides, 
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sorbitol accumulation also leads to a decrease in intracellular myoinositol and results 
in damages of tissues {Nussey & Saffron Whitehead 2001}. Furthermore, 
tissue-damaging reactive oxygen species may be produced through the formation of 
AGEs and altered polyol pathway activity {Inoguchi, Li, et al. 2000}. Since aldose 
reductase is present in the retina, nerve, lens, glomerulus and blood vessel wall, these 
are also the sites that mostly be affected by tissue disruption. The third potential 
cause of tissue damage lies in the increase of blood flow. The arteriolar pressure was 
increased despite of a normal blood pressure. The elevated blood flow may increase 
the entry of potentially damaging proteins into the wall of blood vessels and cause 
tissue devastation {Wilson 1998}. 
Tissue damaged by these three factors can be illustrated in diabetic retinopathy. In a 
normal situation, the capillary blood vessel of retina is wrapped by pericytes that may 
i H ！I 
help to control blood flow. Early features of diabetic retinopathy include increase | 
blood flow, thickening of basement membrane and loss of endothelial cells and 
pericytes. High blood pressure may rupture the weakening capillary and cause 
hemorrhages and accumulation of serum as hard exudates. It may result in capillary 
closure and ischemia. In addition, activated leukocytes and the production of growth 
factors may induce the growth of new vessels. Unfortunately, these new-formed 
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vessels are fragile and can rupture easily. Thus, tissue damages caused by 
hyperglycemia are deleterious and may result in vision loss {Nussey & Saffron 
Whitehead 2001}. 
Tissue damages caused by sustained hyperglycemia result in diabetic complications 
including retinopathy with risk of vision loss; nephropathy resulting renal failure; 
peripheral neuropathy with foot ulcers and the potential amputation; autonomic 
neuropathy with gastrointestinal, cardiovascular and sexual dysfunction. Moreover, 
patients with diabetes have increased risks of hypertension, abnormalities in 
lipoprotein metabolism, and periodontal diseases. They are also in high risk of 
having atherosclerotic, cardiovascular, peripheral vascular, and cerebrovascular 
i 
disease {The Expert Committee on the Diagnosis and Classification of Diabetes 
丨!I 
Mellitus 2001}. Since the resulting symptoms affect the whole body and require ‘ 
chronic treatment, management of hyperglycemia is critical to our health. I 
1.2 Actin 
Actin, one of the most versatile and abundant proteins in eucaryotic cells {Bray 2001}, 
plays an important role in maintaining normal body activities. Actin filaments, 
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which are made up of actin molecules and a number of actin-binding proteins, are 
highly dynamic structures. They normally exist in bundles or networks and are 
usually found in the cell cortex just beneath the PM. The organizational flexibility 
of the actin filaments permits a cell to interact with the continuous changes in the 
cellular environment. 
1.2.1 Function of Actin 
The diverse roles of actin filaments are essential to maintain a normal cellular 
functioning. First of all, actin filaments define organelle position by connecting 
t j 
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organelles and protein complexes with cell cortex. Secondly, they serve as tracks for j 
intracellular transportation. For instance, the Listeria monocytogenes, a 
！I 
microorganism that causes severe food poisoning in humans, propels within and ； 
spreads between the host cells by controlling the host's actin-based motility system 'i 
{Goldberg 2001}. Listeria forms an actin tail to propel the organism through the 
cell cytoplasm. To spread to the adjacent cell，Listeria pushes against the membrane 
to form protrusion with the organism at the tip. The adjacent cell then takes up both 
the protrusion and the organism by the process of endocytosis. Thirdly, actin 
filaments promote cell locomotion by the formation of actin structures such as 
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lamellipodium. Lamellipodium is a board membrane protrusion that projects 
outward from leading end of the cell membrane and attaches to the nearby substratum. 
This attachment acts as anchor and pulls the tail end of the cell toward the cell body. 
Fourthly, actin filaments provide structural support and define cell shape by forming a 
scaffold underlying the cell body. The actin network helps support and stiffen the 
PM. This structural enhancement allows the cell to perform many different tasks. 
On one hand, they can push the PM outward to form membrane projections such as 
microvilli. On the other hand, during cell division, PM is pushed inward by the 
formation of the contractile ring composed mainly of actin filament and myosin-II 
filaments. Finally, actin is the main component of the thin filament in sarcomere, 
} 
which in turn is the basic unit of a muscle fiber. The ability of muscle contraction j 




One interesting example of actin functioning is the involvement of actin in the ？| 
transport of synaptic vesicles in neurons. The neurotransmitter-containing synaptic 
vesicles are responsible for the transmission of nerve impulse between neurons. 
Movement of synaptic vesicles to the PM is facilitated by cytoskeleton. The arrival 
of action potential at the nerve terminal triggers the exocytosis of synaptic vesicles 
and therefore the release of neurotransmitter into the synaptic cleft. To avoid the 
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failure of synaptic transmission, rapid replenishment of synaptic vesicles must occur. 
Indeed, there is a reserve pool of synaptic vesicles locating within the presynpatic 
terminal {Greengard, Valtorta, et al. 1993}. A family of phosphoproteins called 
synapsin reversibly tether synaptic vesicles with the actin cytoskeleton in the reserve 
pool {Hilfiker, Pieribone, et al. 1999}. In response to the physiological requirement, 
these replacement vesicles are recruited to the releasable pool for later 
neurotransmitter release. 
1.2.2 Actin Accessory Protein 
More than 60 different accessory proteins have been identified and their bindings with j 
丨I 
i i 
the actin filaments provide structural and functional advantages. For example, 
cross-linking proteins such as a-actinin and filamin control the tertiary structures of 
I 
actin filaments into bundles or networks respectively; monomer-binding proteins 丨! 
including thymosin and profilin affect the rate of actin polymerization; 
filament-capping proteins such as CapZ prevent the monomer exchange at the capped 
end; actin-depolymerizing proteins such as cofilin accelerate minus end 
depolymerization； and force-generating proteins such as myosin produce force and 
movement at the expense of an ATP molecule {Southwick, Purich, et al. 2000}. The 
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interaction of the accessory proteins allows the cells to perform various functions and 
tackle cellular problems. 
1.2.3 Actin Polymerization 
Actin filament is highly dynamic as it reorganizes continuously in response to cellular 
and environmental changes. The basic structural subunit of an actin filament is 
globular actin (G-actin) {Bray 2001}. Each G-actin equips with either an ATP or 
adenosine diphosphate (ADP). G-actin monomer interacts with each other and 
assembles into a two-stranded helical filamentous actin (F-actin) polymer. The 
I 
assembly is accompanied by the hydrolysis of ATP to ADR ATP hydrolysis 
i i 
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Instead，the stored energy released from ATP hydrolysis provides a driving force for 
‘ 
actin depolymerization {Lodish 1995}. 丨  
The polymerization of actin filament occurs in three phases. There is an initial lag 
phase as G-actins begin to aggregate into short fragments. A rapid polymerization 
phase follows in which short fragments elongate by adding G-actins on both ends. 
The steady state phase is accomplished when the concentration of G-actin is in 
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equilibrium with the filaments. This particular concentration of G-actin during 
steady state is called the critical concentration. Moreover, the polymerization rate is 
different at the two ends of the actin filament� In fact, the plus end of the actin 
filament grows five to ten times faster than the minus end {Lodish 2000}. As a 
result, if the G-actin concentration falls between the critical concentrations of plus and 
minus ends, a treadmilling type of mechanism is employed. Without changing the 
length of the filament, actin monomer is continuously added to the plus end and 
moved toward the minus end. Eventually, it will be dissociated from the minus end. 
Treadmilling is an important phenomenon as it can generate force and movement 
resulted from the site-specific actin polymerization. Lamellipodia extension is an 





1.3 Interaction between Insulin, GLUT4 and Actin in Glucose Homeostasis 
M 
A number of studies have identified the ability of insulin to induce actin remodeling. 
It is also widely accepted that actin is involved in the cellular transport of organelles 
and vesicles including the synaptic vesicles transport in neurons {Hilfiker, Pieribone, 
et al. 1999}. Thus, it is conceivable that actin reorganization may also involve in the 
translocation of GLUT4 to the PM. The regulation of glucose uptake by insulin in 
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skeletal muscle is critical for the maintenance of glucose homeostasis {Jackson, 
Bagstaff, et al. 2000}. Since glucose transport is the rate-limiting step for skeletal 
muscle in glucose metabolism, aberrant insulin-induced GLUT4 translocation may 
affect the glucose homeostasis and contribute to insulin resistance. 
1.3.1 Insulin-Induced Actin Remodeling 
Insulin-induced actin remodeling is ubiquitous in a variety of cell types including 
isolated rat adipocytes {Omata, Shibata，et al. 2000}, 3T3-L1 adipocytes {Wang, 
Bilan, et al. 1998} and L6 myotubes {Tsakiridis, Vranic, et al. 1994}. In 
unstimulated cells, actin filaments are emerged as stress fibers. This long 
,1 > 
microfilament bundles span the cell longitudinally. Insulin stimulation elicits a 
！I 
dramatic reorganization of actin filaments into radially oriented actin aggregations. ‘ 
1* 
These structures projects from the dorsal surface and forms membrane ruffles. 丨, 
These actin filaments cross-link with each other and form mesh-like structures with 
interdigitating branches. They are variable in length and size and are located on 
dorsal surface of PM. Under the view of the inverted microscope, these 
aggregations are mostly found near the nuclei of the cells. They appear as early as 3 
min after the insulin stimulation. In addition, the length of the actin aggregations 
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increases through time. By 10 min of insulin treatment, the aggregations are the 
most pronounced. These actin structures will begin to condense and break into small 
fragments. They appear as dense spots and only traces of actin structures remain 
after 30 min of insulin treatment. Throughout the stimulation, insulin does not alter 
the structure of long actin stress fibers. 
1.3.2 Actin Remodeling and Insulin-Induced GLUT4 Translocation 
Insulin-mediated glucose transport can be described as the translocation of GLUT4 
1 
from the intracellular compartment to the PM of target cells. At the basal state, there 
> j » 
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are about 90% of GLUT4 located in the intracellular compartments. Insulin | 
‘ i  
mobilizes GLUT4 to attain a new equilibrium state that about 30% is now inserted on 
j I 
i 
PM {Shepherd & Kahn 1999}. Besides, insulin also promotes the PI3-K sensitive ‘ 
‘ J 
i* 
extemalization of GLUT4 by accelerating the movement of GLUT4 from early 'fi 
endosome to the PM {Foster, Li, et al. 2001}. In neuron, synaptic vesicles are 
transported and accumulated at the PM using the actin transport system. Thus, it is 
convincible that actin reorganization may also involve in the translocation of 
GLUT4-containing vesicles to the PM. Indeed，study from Tong et al has revealed 
the colocalization of GLUT4 with actin structures at the dorsal surface after insulin 
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stimulation. Jasplakinolide, drug that affect actin filament stability, reduced GLUT4 
appearance at the cell surface after insulin treatment {Tong, Khayat, et al. 2001}. In 
addition, intact actin network is necessary for the exocytotic recruitment of GLUT4 
{Omata, Shibata, et al. 2000}. Actin disassembly has also been shown to reduce 
glucose uptake {Tsakiridis, Vranic, et al. 1994}. As a result, actin filaments may 
directly participate in controlling the GLUT4 vesicle trafficking. Completed intact 
actin reorganization may play a critical role in insulin-mediated GLUT4 translocation 
[ 
and thereby control the glucose uptake. ！ 
1 
1.3.3 Involvement of Insulin Signaling Molecules in Actin Remodeling 
I -
I , ' 
i > ' 
I 
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The membrane-ruffling phenomenon is mainly mediated by the activation of PI3-K 丨 
！ 
pathway. PI3-K is essential to actin remodeling and glucose uptake. PI3-K 'i 
‘ ？丨 
inhibitor such as wortmannin completely blocked the formation of insulin-induced 
actin structures and glucose uptake {Somwar，Niu, et al. 2001}. In fact, the p85 
subunit of PI3-K was found to colocalize with actin structures in L6 myotubes 
{Khayat, Tong, et al. 2000} and IRS-1, PI3-K and cytoskeletal elements in 3T3-L1 
adipocytes {Clark, Martin, et al. 1998}. It is believed that insulin causes the 
translocation of PI3-K to GLUT-containing vesicles and sequentially propagates the 
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insulin-signaling pathway and stimulates the translocation of GLUT vesicles to the 
cell surface. Rac, a GTP-binding protein that is activated by Ras, is also a critical 
protein leading to actin remodeling. Transient transfection of dominant inhibitory 
Racl prevents insulin-induced dorsal actin reorganization and blocks GLUT4 
translocation to the cell surface {Khayat, Tong, et al. 2000}. Rac appears to locate 
downstream of PI3-K in the pathway regulating membrane ruffles {Tsakiridis, Vranic， 
et al. 1994 }. 
f 
！ 
Cytochalasin D (CD)，a widely used inhibitor of actin filament formation, inhibited 





on tyrosine phosphorylation of IRS-1, binding of PI3-K to ERS-l {Tsakiridis, Vranic, 1 
- ,J ‘ . � et al. 1994} and stimulation of PI3-K {Wang, Bilan, et al. 1998}. However, CD 丨 
！I 
significantly diminishes the insulin-mediated association of IRS-1, p85a and pilOp of 
•j ！丨 
PB-K with the GLUT-containing vesicles {Wang, Bilan, et al. 1998}. Thus, the ？i 
cellular insulin-induced actin reorganization is not required for the activation of 
insulin signaling molecules but instead provides a site for communication of signaling 
molecules. 
Intact actin filaments are essential for the propagation of insulin signals leading to the 
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activation of the MAPK pathway {Tsakiridis, Wang, et al. 1997}. The treatment 
with CD in insulin-stimulated cells abolishes DNA synthesis. Moreover, activation 
of Ras, tyrosine phosphorylation of p38 MAPK and She, and the binding of Grb2 are 
also affected {Tsakiridis, Bergman, et al. 1998}. Taken together, very early events 
of insulin action are not dependent on the actin remodeling. The possible 
actin-associated step may locate between She phosphorylation and Ras activation. 
Therefore, actin reorganization governs the mitogenic action of insulin probably 
through tethering the signaling molecules together for communication. 
PI3-K pathway is responsible for GLUT4 translocation. In addition, it has also been 
reported that the MAPK pathway controls its activation. There is a differential 
sensitivity of GLUT4 translocation and glucose uptake to wortmannin: in a low dose 
of wortmannin. GLUT4 translocation is unaffected while glucose uptake is 
abolished. Thus, a successful glucose uptake cannot be relied on GLUT4 
translocation alone. On the other hand, P38 MAPK phosphorylation is also reduced 
by a low wortmannin concentration through the inhibition of an upstream 
insulin-signaling target. Unfortunately, the identity of this wortmannin-sensitive 
target remains to be defined {Somwar, Niu, et al. 2001}. However, it is convincible 
that full stimulation of insulin-stimulated glucose uptake may require corresponding 
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GLUT4 translocation and activation. 
1.3.4 Actin Remodeling and Insulin Resistance 
Taken together, the insulin-induced GLUT4 translocation and activation are depended 
on an intact actin network and insulin-stimulated actin reorganization. The newly 
formed actin network may allow correct sequential activations in insulin signaling 
pathway by distributing the signaling molecules to proper locations. In addition, the 
actin reorganization and the formation of membrane ruffles may also directly 
participate in the translocation of GLUT4. Nowadays, despite of numerous 
researches, the pathology of insulin resistance is still unclear. Since actin 
disassembly abolishes GLUT4 translocation, aberrant GLUT4 translocation caused by 
actin disruption affects glucose homeostasis and may contribute to insulin resistance. 
1.4 Hypothesis and Objective 
1.4.1 Rationale 
Insulin resistance, the ineffectiveness of insulin to stimulate glucose uptake, is a major 
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characteristics of Type II DM and obesity. Although insulin resistance is well 
characterized, the exact mechanism remains unclear. Pancreatic B cells compensate 
for insulin resistance by over-secreting insulin, leading to hperinsulinaemia. Other 
metabolic disturbances including hyperglycemia, hypercholesterolaemia and elevation 
in FFA levels are also common in patients with DM. Previous studies demonstrate 
the participation of the actin cytoskeleton in the translocation of GLUT4 following 
insulin stimulation. It is conceivable that these metabolic derangements may further 
perpetuate insulin resistance, by interfering with the actin reorganization. 
1.4.2 Hypothesis 
Preincubation of L6 myotubes in conditions of insulin resistance would suppress actin 
remodeling and the association of GLUT4 with actin filaments, leading to impairment 
of insulin-medicated glucose uptake. It is plausible that interference of actin 
dynamics may contribute to insulin resistance in vivo. 
1.4.3 Objective 
1. To demonstrate insulin can stimulate actin reorganization and GLUT4 
31 
translocation in L6 myotubes 
2. To examine the effect of preincubation in conditions of insulin resistance on 
actin reorganization, GLUT4 translocation and glucose uptake in L6 myotubes 




CHAPTER TWO MATERIALS AND METHODS 
2.1 Materials 
Tissue culture medium, serum, and other tissue culture regents were purchased from 
Gibco™ Invitrogen Corporation (Grand Island, NY，USA). Humulin R insulin was 
purchased from Lilly France S.A. (Fegersheim, France). ProLong Antifade 
mounting solution, Oregon Green-phalloidin, rhodamine-phalloidin and Alexa Fluor 
anti-rabbit or anti-mouse secondary antibodies were purchased from Molecular 
Probes Inc. (Eugene, Oregon, USA). Polyclonal rabbit c-myc antibody was 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Monoclonal 
anti-P-actin antibody, OA, LA, PA, CHO hemisuccinate, cytochalasin B, 
methyl-p-cyclodextrins, and bovine serum albumin (BSA) were purchased from 
Sigma-Aldrich (St Louis, MO, USA). Bio-Rad Protein Assay was purchased from 
Bio-Rad Laboratories (Hercules, CA, USA). 2-deoxy-[^H]D-glucose was purchased 
from Amersham Pharmacia Biotech UK Limited (Little Chalfont, Buckinghamshire, 
England). OptiPhase "HiSafe" 2 Scintillation Solution was purchased from Wallac 
Scintillation Product (Wallac Oy, Turku, Finland). LR White Hard Grade 
Embedding Resin was purchased from London Resin Company Ltd. (Reading, 
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Berkshire, England). 18nm Colloidal Gold-AffiniPure donkey anti-rabbit and 12nm 
Colloidal Gold-AffiniPure goat anti-rabbit antibodies were purchased from Jackson 
ImmunoResearch Laboratories, Inc (West Grove, PA, USA). Chemicals for the 
TEM study were kindly provided by Dr. F. L. Chan (The Chinese University of Hong 
Kong, Hong Kong, China). Unless otherwise specified, chemicals used in our study 
were provided by Lee Hysan Clinical Research Laboratories (Shatin, Hong Kong, 
China). 
The L6 myotubes, which differentiate in vitro from myoblasts into multinucleated 
myotubes by multiple cell fusions, was derived from rat thigh skeletal muscle by 
Yaffe et al in 1968 {Yaffe 1968}. GLUTl, GLUTS, and GLUT4 are all found in L6 
cells. GLUTS is largely found on the cell surface, whereas half of the GLUTl is 
intracellular and respond to insulin. GLUTl is believed to be responsible for the 
basal glucose transport and is found during all stages of cell development. The 
amount of GLUTl is very high in the myoblast stage. Its amount decreases sharply 
during alignment and reaches the lowest amount in myotubes stage {Mitsumoto, 
Burdett, et al. 1991}. In addition, there is only a marginally increase of GLUTl in 
PM after insulin stimulation {Mitsumoto & Klip 1992}. Meanwhile, in contrast to 
GLUTl, the amount of GLUT4 is the lowest in myoblast and alignment stage and 
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sharply increases in the myotubes stage {Mitsumoto, Burdett，et al. 1991}. The 
inulsin-mediated glucose uptake is negligible in myoblasts, and increases with cell 
alignment and fusion {Mitsumoto & Klip 1992}. 
Numerous studies have been established to show that L6 cell line is a suitable cell 
culture system to study glucose uptake. First of all, the development of L6 
myoblasts to myotubes closely resembles to that of embryonic muscle in vivo. They 
both multiply, align and fuse to form multinucleated myotubes. Secondly, L6 cells 
are responsive to insulin and serum treatments. The insulin-induced glucose uptake 
is about 200% in serum-deprived L6 myotubes with respect to basal rate {Klip, Li, et 
al. 1984}. Thirdly, glucose uptake is rate limiting and GLUT activity is not affected 
by changes of cell shape and substratum after trypsinization and subculture {Klip, 
Logan, et al. 1982}. Fourthly, human muscle cells have been used to study their 
insulin-mediated glucose uptake. The results are highly comparable with those of rat 
L6 myotubes. In fact, they both show similar dose-dependent response and Km 
values for glucose uptake {Sarabia, Ramlal, et al. 1990}. In addition, cytochalasin B 
(CB), a fungal metabolite that specifically binds to GLUT, is used to measure 
non-specific glucose uptake. This inhibitor results in inhibition of transport activity 
by binding with GLUT in a one-to-one ratio. The use of CB provides a more 
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accurate measurement of glucose uptake {Klip, Logan, et al. 1982}. Thus, L6 
myotubes are indeed an accurate tool to investigate glucose transport. 
In our study a modified family of L6，the L6 GLUT4myc myotubes, was used. The 
presence of an exofacial c-myc epitope tag on GLUT4 enables us to identify its 
intracellular position via immunofluorescence method. It allows us to estimate the 
proportion of GLUT4 at the cell surface or the total content in either intact or 
permeabilized cells, respectively. They also express more than ten times higher level 
of GLUT4myc than do any of the endogenous transporters {Tong, Khayat, et al. 
2001}. As a result, the use of L6 GLUTmyc myotubes can be an effective tool to 
study insulin action {Ueyama, Yaworsky, et al. 1999). 
2.2 Cell culture 
2.2.1 Cell Culture 
Mediums used in our study: 
1. Growth medium: a - Eagle's minimum essential medium (a -MEM) with 
10% (v/v) fetal bovine serum (FBS) and 1% (v/v) antibiotic-antimycotic 
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(AB) solution (10,000U/ml penicillin Q lOmg/ml streptomycin and 25mg/inl 
amphotericin B) 
2. Differentiation medium: a -MEM with 2% (v/v) FBS and 1% (v/v) AB 
3. Freezing medium: a -MEM with 10% (v/v) FBS, 1% (v/v) AB and 10% 
dimethyl sulfoxide (DMSO) 
All medium and chemicals used for cell culture were temperature pre-equilibrated at a 
37°C water bath. At the beginning of study, ampoules of L6 skeletal muscle cells 
expressing GLUT4inyc were kept in liquid nitrogen. At the start of cell culture, L6 
ampoule was thawed in a 37°C water bath. Sterile pipette was used to resuspend the 
cells three to five times. Cells were added slowly and directly to 10ml growth 
medium in a culture flask and incubated in an atmosphere of 5% CO2 at 37®C. 
Medium was changed with fresh growth medium four hours after the subculture to 
remove DMSO. Thereafter, growth medium was changed at least every 48 hours. 
Cells were maintained for 10 to 15 passages before a new batch of L6 cells would be 
started. 
Trypsinization of cells was done at less than 60 to 80% confluency to maintain 
passage and seeding for experiments. Cells subculturing was done as the following: 
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the medium was decanted and cells were rinsed with phosphate-buffered saline (PBS) 
twice. Then, cells were trypsinizated with 3ml 0.25% (w/v) trypsin for 
approximately 5 to 10 seconds. Flask was rocked side-to-side to ensure the cell 
surface was covered with trypsin. Trypsin was decanted and the flask was placed 
in 37�C incubator for 30 seconds. Differentiation medium (6ml) was added and the 
flask was tapped firmly. Cells were observed under a microscope to ensure that cells 
had detached from the flask. To maintain passage, approximately 1 X lO^ cells/ml 
cells were added to a flask with 10ml growth medium. 
For myotubes differentiation, myoblasts were plated in differentiation medium at 
approximately 4 X lO* cells/ml, fed fresh medium every 48 hours and used six to 
eight days after seeding. For glucose uptake, cells were grown to the stage of 
myotubes in 12-well plates. Meanwhile, for IM study, cells were grown on 
25-mm-diameter glass coverslips placed in 6-well plates. Finally, for TEM study, 
cells were grown in 100 X 20nmi culture dish. 
For freezing down of cells, trypsinizated cells were diluted with freezing medium at a 
final concentration approximately 2X1 (Z cells/ml. Diluted cells were then 
transferred 1.0 to 1.5ml per cryotube. They were frozen at once in acetone with dry 
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ice or placed in the -80®C freezer overnight and then into liquid nitrogen for storage. 
Cell culture was maintained as described previously {Khayat, Tong, et al. 2000}. 
2.2.2 Reagents Preparation and Incubation 
Glucose and insulin were diluted in double distilled water (DD-H2O) to the desired 
concentrations. For the FFA incubation experiments, OA, LA and PA were selected. 
Both OA and LA are water-soluble as they are pre-equipped with 
methyl-p-cyclodextrins to facilitate their dissolutions in culture medium. Stock 
solutions of PA (30mM) and CHO (lOOmM) were dissolved in 100% methanol 
(MeOH) and 100% ethanol (EtOH) respectively and were then diluted with DD-H2O 
to the desired concentration. For the incubation experiments, cells were incubated in 
various concentrations of insulin (up to lOOjjM) and glucose (up to 25mM), FFA (up 
to 75jjM) or CHO (up to 60^lM) for up to 24 hours. Same amount of reagents were 
added to the medium during the serum-deprived period. 
2.3 2-Deoxyglucose Uptake 
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L6 GLUT4inyc muscles cells were grown to the stage of myotubes in 12-well plates. 
Myotubes were deprived of serum for 5 hours and treated with lOOnM insulin for 30 
min at After discarding the medium, cell monolayers were rinsed twice with 
HEPES-bufFered saline (140mM sodium chloride, 2.5mM magnesium sulphate, ImM 
calcium chloride, 5mM potassium chloride, pH 7.4) and the remaining medium was 
aspirated. Glucose uptake was quantitated by exposing each well with 0.5ml lO^iM 
2-deoxy-[^H]D-glucose (IjiCi/ml). Nonspecific uptake was determined by 
quantitating cell-associated radioactivity in the presence of 0.5ml lOpM CB per well, 
which blocks transporter-mediated uptake. At the end of 5-minute period, the uptake 
solution was rapidly aspirated and the cells were washed three times with 1ml 
ice-cold isotonic saline. Cells were allowed to air-dry and were lysed in 300|il 
0.05N sodium hydroxide overnight. 
The associated radioactivity was determined by liquid scintillation counting. 
Samples were neutralized in 30jil 5N hydrochloric acid. Sample aliquot (250jil) was 
added to scintillation solution (3ml) and was counted using the Beckman LS 5801 
Liquid Scintillation Counter (Irvine, CA, USA). Bio-Rad Protein Assay was used to 
determine the protein concentration in each well. Absorbance was measured by a 
TECAN SpectraFluor Plus Microplate Reader from TECAN Austria 
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Gesellschaft.M.B.H. (Untersbergstrasse, Grodig, Austria). BSA was used as the 
standard of the assay. The absorbance of protein was measured at wavelength 
590nm with the Magellan Reader Software Version 2. Protein concentrations were 
calculated, using its absorbance and compared it to the standard curve (graph. 1). 
The final radioactivity level in each well was calculated by subtracting the glucose 
uptake level from the non-specific uptake and adjusted with the protein concentration. 
{Tong, Khayat, et al. 2001}. 
2.4 Immunofluorescence Microscopy 
2.4.1 Permeabilized Cell Staining 
L6 GLUT4myc muscles cells were grown to the stage of myotubes on 
25-mm-diameter glass coverslips placed in 6-well plates. Myotubes were deprived 
of serum for 3 hours and treated with lOOnM insulin for up to 30 min at 37®C. After 
discarding the medium, myotubes were fixed with ice-cold 3% (v/v) 
paraformaldehyde (FFA) in PBS for 5 min on ice and the plate was then transferred to 
room temperature for another 30 min fixation. Fixative was discarded and the cells 
were incubated with 0.05M ammonium chloride for 10 min to neutralize excessive 
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Graph. 1 Example of protein standard curve. Known concentrations of BSA 
were used as protein standards and the absorbances were measured as described in 
Ch. 3 Materials and Methods. The linear regression equation obtained from the 
standard curve was used to estimate the protein concentration of the sample. Each 



































































































aldehyde groups. Cells were washed with PBS three times and were permeabilized 
with 0.1% Trition X-100 for 3 min. Fixed and permeabilized cells were washed with 
PBS and blocked with 0.1% BSA for 3 min. 
Labelings of actin filament and GLUT4 in fixed and permeabilized myotubes were 
carried out as described previously {Khayat, Tong, et al. 2000}. Briefly, for labeling 
of actin filaments, cells were incubated for 30 min with either rhodamine- (1:1000 
dilution), Oregon green-phalloidin (1:1000 dilution) or monoclonal anti-p-actin 
antibody (1:250 dilution). For labeling of GLUT4myc, cells were incubated for 30 
min at room temperature with polyclonal rabbit c-myc antibody (1:50 dilution). 
Following the incubation of primary antibodies the cells were washed with PBS and 
incubated in dark with Alexa Fluor anti-rabbit or anti-mouse secondary antibodies 
respectively, at a dilution factors of 1:500 for 30 min at room temperature if needed. 
For double staining of actin and GLUT4, cells would be incubated with polyclonal 
rabbit c-myc antibody as primary antibody for 30 min. Then the anti-actin antibody 
would be mixed with Alexa Fluor secondary antibodies and incubated in dark for 
another 30 min. After the antibodies incubation, cell monolayers were washed with 
PBS and mounted in ProLong Antifade solution onto glass slides. 
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For fluorescence microscopy, cells were examined with a Nikon Eclipse TE 300 
Inverted Microscope with a Nikon Plan Fluor ELWD 400X/0.45 objective from 
Nikon Corporation (Shinagawa-ku，Tokyo, Japan). Digital images were acquired 
using a Quantix Digital Camera from Photometries (Tucson, AZ, USA). The 
software used was the MetaMorph Imaging System Version 4.01 from University 
Imaging Corporation (West Chester, PA, USA). 
2.4.2 Membrane-Intact Cell Staining 
Cell surface immunostaining was carried out as described above for L6 myotubes 
with the following modifications: the 6-well plate was placed on ice immediately 
after 10-minute insulin treatment. Cells were washed in ice-cold PBS and were 
fixed with ice-cold 3% (v/v) PFA in PBS for 5 min. After washing with ice-cold 
PBS, cells were incubated in primary antibody for 1 hour at 4°C, followed by 
secondary antibodies for 30 min at 4�C in the dark. Cells were washed thoroughly 
with PBS three times and were fixed with 4% (v/v) PFA for 30 min at room 
temperature. Finally, cells were washed, mounted and examined as described above. 
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2.4.3 The Analysis of Actin Remodeling Reduction 
Images acquired from various conditions mimicking insulin resistance were enlarged 
with locked aspect ratio to the standard size of 85mm * 65mm. Grids with 5mm^ 
grid sizes were applied to the images. The numbers of squares containing new actin 
structures were counted against the total number of squares occupied by the 
myotubes. By comparing with the control，we estimated the reduction of actin 
remodeling in the stimulated cells. 
2.5 Live Image Microscopy 
For live images, cells were examined with the Leica DM-IRB Inverted Research 
Microscope with a Leica 200X/0.4 objective from Leica Microsystem Wetzlar GmbH 
(Emst-Leitz-StraBe, Wetzlar, Germany). Images were captured with either the Leica 
DC Digital Camera through Leica DC Viewer Software Version 3.2.0.0 or the Ricoh 
XR-X3000 camera from Ricoh Company, Ltd from (Shinagawa-ku, Tokyo, Japan) 
2.6 Transmission Electron Microscope Study 
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L6 GLUT4myc muscles cells were grown to the stage of myotubes in 100 X 20mm 
culture dish. Cells were deprived of serum for 5 hours and treated with lOOnM 
insulin for 10 min at 37®C. At the end of 5-hour period, cells were washed briefly 
with PBS and fixed with 4% (v/v) PFA and 0.1% (v/v) glutaraldehyde in O.IM 
cacodylate buffer (pH 7.3) for 45 min. Fixative was discarded and the cells were 
incubated with O.IM ammonium chloride for 1 hour. Cells were washed with 
cacodylate buffer three times for 15 min or stored in cacodylate buffer containing 4% 
sucrose overnight at 4®C. 
Cells were dehydrated in graded EtOH from 30% to 95% at 15-minute interval. 
Finally, the cells were dehydrated in three 15-minute intervals of 100% EtOH. After 
the dehydration, cells were detached from the plastic dish with propylene oxide and 
stored with 100% EtOH in 1.5ml Eppendorf tubes. Cells were then infiltrated with a 
series of LR White embedding resin and 100% EtOH mixtures (table 1) with a gentle 
agitation on a rotor. The resulting mixture was stored in 0.5ml Eppendorf tube and 
centrifliged before they were placed in an oven to polymerize at 55°C for 24 hours. 
The embedding blocks were first sliced with a glass knife using the Leica Ultracut R 
Ultramicrotome from Leica Microsystem Wetzlar GmbH (Erast-Leitz-StraBe, 
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Table.l Ratio of LR White and EtOH used in TEM study. Different 
combinations of LR White and EtOH were used for the embedding of cell samples 
























































































































Wetzlar, Germany). Ultrathin sections (100-120nm thick) were then sliced with a 
Diatome diamond knife (Diatome Ltd, Bid，Switzerland) from the resulting blocks. 
These sections were mounted on 0.2% formver in chloroform coated nickel grids (200 
meshes). Formver-coated grids with sections side down were put on the droplets of 
0.05M Tris-HCl buffer with 0.15M sodium chloride, pH 7.6 (TBS) for 5 min. Cells 
were blocked with BSA in 0.05M TBS containing 0.1% Tween 20 for 15 min. For 
immunogold labeling, cells were incubated with the primary antibodies for 1 to 2 
hours at room temperature or overnight at 4°C. Following this incubation the cells 
were washed three times with 0.05M TBS and subsequently incubated with secondary 
antibodies conjugated to gold for 1 hour at room temperature. Cells sections were 
further washed three times with 0.05M TBS with 0.1% Tween 20 for 15 min. For 
double staining, this staining procedure would be repeated. Grids were allowed to 
air-dry and counter-stain with 4% uranyl acetate for 4 min and lead citrate or lead 
acetate for 2 min. Sections were examined with Hitachi H-7100FA Electron 
Microscope (Tokyo, Japan). Actin and GLUT4 ultrastructures were observed under 
magnifications of 15000X and 30000X. 
2.7 Statistical Analysis 
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Data are expressed in mean 士 SEM. Significance statistical analysis was carried out 
using the paired Student's T-test for comparisons between basal and insulin-mediated 
uptake at the same concentration. In addition, unpaired Student's T-test was used to 
compare glucose uptakes and actin reduction between different concentrations or 
between different conditions. 
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CHAPTER THREE RESULTS 
3.1 Cell Growth 
L6 muscle cells differentiate through multiple cell fusions of myoblasts into myotubes, 
which are large, multinucleated cells. Fig. 2a showed myoblasts attached on the 
surface of the culture plate 4 hours after subculture. On day 1 and 2, cells multiplied 
(Fig. 2b) and began to align (Fig. 2c). On day 4-5, fusions began as myoblasts 
merged into myotubes (Fig. 2d). On day 6-8, approximately 80% of the cells were 
in myotubes state and were ready for experiment (Fig. 2e). 
3.2 Acute Effect of Insulin on L6 myotubes 
To investigate the effect of insulin-mediated actin remodeling and glucose uptake, we 
performed IM, TEM and 2-Deoxyglucose Uptake studies on L6 myotubes. By 
performing the IM study, the spatial relationships of actin and GLUT4myc in 
permeabilized and membrane-intact cells can be revealed before and after insulin 
stimulation. Similarly, the TEM study allows us to have a more concreted evidence 
of actin and GLUT4myc colocalization in an ultra-structural level. In addition, we 
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Fig.2 Differentiation of L6 muscle cells from myoblasts to myotubes. L6 
cells were viewed at 4 hours (a), 1 to 2 days (b and c)，4 to 5 days (d)，and 6 to 8 
days (e) after subculture. The cells were examined in 200X magnification. 
a 8 4 
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have measured glucose uptake under the stimulation of insulin. The degree of 
glucose uptake can be served as an index of insulin responsiveness in L6 myotubes. 
3.2.1 Immunofluorescence Microscopy 
The IM study was performed in permeabilized and membrane-intact cells. Time and 
concentration profiles were first constructed and the spatial relationships of actin and 
GLUT4myc were examined. 
3.2.1.1 The time profile of insulin on actin cytoskeleton in permeabilized L6 
myotubes 
Fig. 3 showed the morphological characteristics of actin cytoskeleton of L6 myotubes. 
Labeling of myotubes with Oregon Green-phalloidin revealed the existence of 
organized stress fiber network (fig. 3a). These networks were consisted of long actin 
microfilament bundles of variable length and thickness, spanning the cell 
longitudinally. They were detected throughout the cell. Stimulation of 
serum-deprived L6 myotubes with lOOnm insulin elicited a reorganization of actin 
filaments into radially oriented actin aggregations. These actin filaments 
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Fig.3 Effects of insulin on actin cytoskeleton in permeabilized L6 myotubes 
(time). Serum-deprived L6 GLUT4myc myotubes were left untreated (a) or 
stimulated with lOOnM insulin for 3 min (c)，10 min (b and d)，20 min (e) and 30 
min (f) at 37�C. The cells were examined in 400X magniHcation and the white 
arrows in the images indicated the newly formed actin structure. The images 
are representatives of at least three experiments. 
Fig 3. Effects of insulin on actin cytoskeleton 
in permeabilized L6 myotubes (time). 
0 min 10 min 
3 min 10 min 
• • 
20 min 30 min 
• • 
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cross-linked with each other and formed mesh-like structures with interdigitating 
branches. They were variable in length and size and were located on top of the 
stress fibers. Under the view of the inverted microscope, these aggregations were 
mostly found near the nuclei of the cells (fig. 3b). They appeared as early as 3 min 
after the insulin stimulation (fig. 3c). In addition, the length of the actin 
aggregations increased through time. The aggregations were the most pronounced 
(fig. 3d) at 10 min of insulin treatment. These actin structures would begin to 
condense and appear as dense spots in the photos. Only traces of new actin 
structures remained after 20 min (fig. 3e) and 30 min (fig. 3f) of insulin treatment. 
3.2.1.2 The concentration effects of insulin on actin cytoskeleton in 
permeabilized L6 myotubes 
Fig. 3 showed the morphological characteristics of actin cytoskeleton of L6 myotubes 
in a concentration gradient. A concentration profile was constructed from OnM (fig. 
3g), InM (fig. 3h), lOnM (fig. 3i), lOOnM (fig. 3j), lOOOnM (fig. 3k) and 6000nM (fig. 
31) of insulin. Increased insulin concentration caused an increase of the degree of 
actin remodeling. An inhibiting effect was observed above lOOOnM of insulin. 
The newly formed insulin-induced actin structures appeared to scatter into small 
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Fig.3 Effects of insulin on actin cytoskeleton in permeabilized L6 myotubes 
(concentration). Serum-deprived L6 GLUT4myc myotubes were left untreated 
(g) or stimulated with InM insulin (h), lOnM (i) lOOnM (j), lOOOnM (k) and 
6000nM (1) for 10 min at 37T. The cells were examined in 400X magnification 
and the white arrows in the images indicated the newly formed actin structure. 
The images are representatives of at least three experiments. 
Fig. 3 Effects of insulin on actin cytoskeleton in 
permeabilized L6 myotubes (concentration) 
OnM l i ^  
mm 
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fragments and distribute unevenly on the surface of the myotubes. 
3.2.1.3 Relationship between actin cytoskeleton and GLUT4myc in 
permeabilized L6 myotubes 
To determine the spatial relationship between actin structures and GLUT4myc after 
insulin stimulation, permeabilized L6 myotubes were stained for actin and 
GLUT4myc. In unstimulated L6 myotubes, actins were appeared as stress fiber 
networks (fig. 4a) while GLUT4myc were located near the nuclei (fig. 4b). After a 
10-minute stimulation of insulin, F-actins aggregated mostly near the nuclei and 
formed membrane ruffles (fig. 4c). Meanwhile, GLUT4myc translocated and 
colocalized with these actin structures (fig. 4d). Figures e and f were images merged 
from the corresponding photos from basal and insulin-stimulated L6 myotubes stained 
with actin and GLUT4myc. 
3.2.1.4 Translocation of GLUT4myc in membrane-intact L6 myotubes 
To examine the translocation of GLUT4myc after insulin stimulation, cell surface 
immunostaining was carried out on L6 myotubes. In the basal state, GLUT4myc 
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Fig.4 Relationship between actin cytoskeleton and GLUT4myc in 
permeabilized L6 myotubes. Serum-deprived L6 GLUT4myc myotubes were 
left untreated (a and c) or stimulated (b and d) with lOOnM insulin for 10 min at 
37°C，followed by fixation and permeabilization. Cells were stained for actin (a 
and b) and GLUT4myc (c and d) as described in Ch. 3 Materials and Methods. 
Figures e and f are images merged from the corresponding photos from basal 
and insulin-stimulated L6 myotubes stained with actin and GLUT4myc. The 
cells were examined in 400X magnification. The images are representatives of 
at least three experiments. 
Fig. 4 Relationship between actin cytoskeleton 
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was not visible (fig. 5a). After the 10-minute insulin treatment, mesh-liked 
GLUT4myc structures were observed on PM (fig. 5b). The newly formed 
GLUT4myc structures were similar in morphology to the actin structures, 
3.2.1.5 Effect of methyl-p-cyclodextrins, MeOH or EtOH in permeabilized 
and membrane-intact L6 myotubes 
The addition of methyl-P-cyclodextrins, MeOH or EtOH alone had no effect on the 
morphology of the myotubes at baseline (fig. 6). The percentage of actin structure in 
insulin-stimulated control myotubes was 26.9 土 0.8% (table. 2). When preincubated 
in cyclodextrin, EtOH or MeOH, the respective insulin-stimulated actin percentages 
were 24.1 土 0.7%, 29.3 土 0.4% or 28.8 ± 0.4% of total myotubes. Thus, the 
presence of these compounds did not affect actin reorganization and GLUT4myc 
translocations following insulin treatment. 
3.2.2 2-Deoxyglucose Uptake 
3.2.2.1 Effects of insulin, methyl-p-cyclodextrins, MeOH and EtOH in L6 
myotubes 
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Fig.5 Translocation of GLUT4myc in membrane-intact L6 myotubes. 
Serum-deprived L6 GLUT4myc myotubes were left untreated (a) or stimulated 
(b) with lOOnM insulin for 10 min at 37�C. Cells were fixed and stained for 
GLUT4myc as described in Ch. 3 Materials and Methods. The cells were 
examined in 400X magm行cation and the white arrows in the images indicated 
the GLUT4myc. The images are representatives of at least three experiments. 
Fig. 5 Translocation of GLUT4myc in membrane-





Fig.6 Effect of methyl-p-cyclodextrin, MeOH or EtOH in pernieahili/ecJ L6 
myotubes. L6 myotubes were preincubated with methyl-p-cyclodextrin (a and 
b), MeOH (c and d) or EtOH (e and f) for 24hr. Serum-deprived L6 
GHJT4niyc myotubes were left untreated (a, c and e) or stimulated (b，d and f) 
with lOOnM insulin for 10 min at 37°C, followed by fixation and 
pernieabilization. Cells were stained for actin as described in Ch. 3 Materials 
and Methods. The cells were examined in 400X magnification and the white 
arrows in the images indicated the newly formed actin structure. The images 
are representatives of at least three experiments. 
Fig 6. Effect of methyl- ^S-cyclodextrins，MeOH 
or EtOH in permeabilized L6 myotubes 
Basal Insulin-stimulated 
• B M 
MeOH MeOH 
• • 
EtOH EtOH  • • 
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Fig.6 Effects of methyl-p-cyclodextrin, MeOH or EtOH in membrane-intact 
L6 myotubes. L6 myotubes were preincubated with methyl-p-cyclodextrin (g)， 
MeOH (h) or EtOH (i) for 24hr. Serum-deprived L6 GLUT4myc myotubes 
were stimulated with lOOnM insulin for 10 min at 37°C, followed by fixation. 
Cells were stained for GLUT4myc as described in Ch. 3 Materials and Methods. 
The cells were examined in 400X magnification and the white arrows in the 
images indicated the GLUT4myc. The images are representatives of at least 
three experiments. 
Fig 6. Effect of methyl- y9-cyclodextrins，MeOH 







Table.2 Effects of preincubations on actin remodeling. L6 myotubes were 
preincubated for 24hr and actin immunostaining was carried as described in Ch. 3 
Materials and Methods. Results shown are combined means 土 SEM from 3 to 5 
experiments. p < 0.001 preincubation conditions compared with respective 
























































































































































































































































































































































































































































































































































































































































































Insulin-mediated glucose uptake study was performed in unstimulated L6 myotubes 
and the fold of increase in glucose uptake was served as reference for later uptake 
comparisons. We also investigated the effect of methyl-P-cyclodextrins, MeOH and 
EtOH preincubations on insulin-stimulated glucose uptake. Table 3 showed the 
effect of insulin on 2-Deoxyglucose uptakes in L6 myotubes. Insulin caused a 189 
±2% increase in glucose uptakes relative to the basal values in the control cells. 
Moreover, the preincubations of methyl-P-cyclodextrins, MeOH or EtOH increased 
insulin-stimulated glucose uptake to 180 土5%, 175 ±2% or 197 土9% respectively. 
Importantly, the presence of methyl-P-cyclodextrins, MeOH or EtOH did not alter the 
insulin-mediated glucose uptake (p = 0.238) when compared with basal control 
uptakes. 
3.2.3 TEM study 
3.2.3.1 Effects of insulin on actin cytoskeleton and GLUT4myc in L6 myotubes 
From the IM results, insulin stimulated the colocalization of actin and GLUT4myc in 
L6 myotubes. To examine the relationship between actin and GLUT4myc at an 
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Table.3 Effects of insulin, methyl - P - cyclodextrins, MeOH and EtOH 
preincubations on glucose uptake. L6 myotubes were preincubated with methyl-p-
cyclodextrin, MeOH or EtOH for 24hr. Glucose uptake were carried out as 
described in Ch. 3 Materials and Methods. All glucose uptakes values were 
expressed in relative units relative to the basal control conditions. Results shown 
are combined means 土 SEM from 5 experiments. A graphic presentation of glucose 
uptake was shown on the bottom of the table. *，p < 0.001 compared with respective 
basal uptake values. 
i 
[ 
Table 3. Effects of insulin，methy卜 
cyclodextrins, MeOH and EtOH Preincubations 
on Glucose Uptake 
^ Control Cyclodextrin EtOH MeOH 
Basal 1 00+000 097+002 1 06+005 090+001 
iiVv — \J*\J\J vi/ — \Ji\JLi 丄 y J t J x J — \Jt\Ji 
Glucose Uptake Insulin . 1.89iQ.Q2 1.80i0.05 1.97iQ.Q9 1.75 土 0.02  
Ratio 1.89 1.秘 1.86 
2.50 r  
OJ 
^ ^ — — * 
Control Cyclo500 MeOH 0.165% EtOH 0.5% 
p < 0.001 compared with respective basal uptake values. 
c； -3 = 
ultra-structural level, TEM was carried out. Actin was decorated with 12nm gold 
particle whereas GLUT4myc was identified with 18nm. In basal L6 myotubes, 
actins were mostly found along the stress fibers while GLUT4myc were located near 
the nuclei (fig. 7a). Very few GLUT4myc particles were found near the PM (fig. 7b). 
Insulin stimulation translocated GLUT4myc to the PM and colocalized them with 
actins (fig. 7d). Importantly, a finger-liked protrusion with both actin and 
GLUT4myc gold particles from PM was observed. Despite the translocation of 
GLUT4myc to the PM, the majority of GLUT4myc remained in the perinuclear 
intracellular compartment. Hence, labeling of GLUT4myc near the nuclei remained 
abundant following insulin stimulation (fig. 7c). 
3.3 Effect of high glucose and high insulin incubation in L6 myotubes 
Hyperglycemia and hyperinsulinemia are common in patients with diabetes. To 
understanding the effect of hyperglycemia and hyperinsulinemia on L6 myotubes, 
cells were preincubated with high concentration of insulin and glucose for 24 hours. 
3.3.1 Immunofluorescence Microscopy 
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Fig.7 Distribution of actin cytoskeleton and GLUT4myc at basal state in L6 
myotubes (TEM). Serum-deprived L6 GLUT4myc myotubes were left 
untreated, followed by fixation and permeabilization. Cells were stained for 
actin (12nm) and GLUT4myc (18nm) as described in Ch. 3 Materials and 
Methods. The cells were examined in 30000X magnification and images around 
the nucleus and PM were taken. The t indicated the actin structure 
本 I 
whereas the 丁 represented the GLUT4myc. 
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Fig.7 Effects of insulin on actin cytoskeleton and GLUT4myc in L6 myotubes 
(TEM). Serum-deprived L6 GLUT4myc myotubes were stimulated (c and d) 
with lOOnM insulin for 10 min at 37°C，followed by fixation and 
permeabilization. Cells were stained for actin (12nm) and GLUT4myc (18nm) 
as described in Ch. 3 Materials and Methods. Cells were examined in 30000X 
magnincation and images around the nucleus and PM were taken. The •‘ 
represented the actin structure whereas the 令 indicated the GLUT4myc. 
Fig. 7 Distribution of actin cytoskeleton and 
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3.3.1.1 High insulin and high glucose preincubation in permeabilized L6 
myotubes 
The effect of insulin and glucose preincubation were shown in Fig. 8. At low 
concentration of glucose and insulin, the growth of cells was normal. However, as 
the concentration of insulin increased above 50nM, cells appeared to be narrower and 
fusions to myotubes were also reduced. When basal cells preincubated with glucose 
and insulin were viewed under IM, the stimulated myotubes were shorter and slender 
compared with control myotubes. Aberrant insulin-stimulated actin mesh formation 
was observed in cells preincubated with glucose and insulin. At 25mM glucose, the 
degree of actin remodeling diminished with increasing insulin concentrations (fig 8a 
to 8h). At lOOnM insulin and 25mM glucose, the reduction was the most noticeable 
and was significantly reduced to 64.7%, (p < 0.001) when compared with control cells 
(table. 2a). The actin aggregations in the stimulated cells were shorten in length and 
were broken into small fragments. 
3.3.1.2 Effect of high insulin and high glucose incubation in membrane-intact 
L6 myotubes 
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Fig.8 High insulin and high glucose preincubation on actin cytoskeleton in 
permeabilized L6 myotubes. L6 myotubes were left untreated (a) or 
preincubated with 25mM glucose and OnM (b)，5nM (c)，50nM (d) or lOOnM (e) 
insulin for 24 hours. Serum-deprived L6 GLUT4myc myotubes were 
stimulated with lOOnM insulin for 10 min at 37°C, followed by fixation and 
permeabilization. Cells were stained for actin as described in Ch. 3 Materials 
and Methods. The cells were examined in 400X magnification and the white 
arrows in the images indicated the actin structures. The images are 
representatives of at least three experiments. 
Fig.8 High glucose and high insulin 
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To determine translocation of GLUT4myc after preincubation, L6 myotubes were left 
untreated (fig. 9a) or incubated with glucose and insulin (fig. 9b and 9c). The 
morphological changes during cell growth were similar to basal permeabilized cells 
preincubated with glucose and insulin. When basal cells preincubated with glucose 
and insulin were viewed under IM, no GLUT4myc was visible. Insulin stimulation 
caused the translocation of GLUT4myc to the PM. By comparing with control, there 
were reductions in insulin-induced recruitment of GLUT4myc. 
3.3.2 2-Deoxyglucose Uptake 
3.3.2.1 Effect of high insulin and high glucose incubation in L6 myotubes 
To determine the effect of hyperglycemia and hyperinsulinemia on glucose uptake, L6 
myotubes were exposed to high insulin and high glucose for 24 hours. All uptake 
values were compared with basal control glucose uptake. Their effects on glucose 
uptake were dose-dependent reductions at 25mM glucose and between 25 to lOOnM 
insulin (table. 4). Insulin caused in increase in glucose uptake from 100 ±0% to 204 
土 3% in control L6 cells. A 24-hour 25mM glucose and 25nM insulin preincubation 
increased basal and insulin-stimulated uptake to 140 士 6% and 225 土 17% 
56 
Fig.9 High glucose and high insulin and CHO preincubations on GLUT4myc 
translocation in membrane-intact L6 myotubes. L6 myotubes were left 
untreated (a) or preincubated with 25mM glucose and 5nM (b)，lOOnM (c) 
insulin or with EtOH and OjLiM (d)，lOjLiM (e), or 50|iM (f) CHO for 24 hours. 
Serum-deprived L6 GLUT4myc myotubes were stimulated with lOOnM insulin 
for 10 min at 37"C, followed by fixation. Cells were stained for GLUT4myc as 
described in Ch. 3 Materials and Methods. Cells were examined in 400X 
magnification and the white arrows in the images indicated the GLUT4myc. 
The images are representatives of at least three experiments. 
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Fig.9 FFA preincubation on GLUT4myc translocation in membrane-intact 
L6 myotubes. L6 myotubes were preincubated with cyclodextrin and OfxM (g), 
lOnM (h)，50nM � OA or OfxM (j), lOnM (k)，50nM � LA or with MeOH and 
OPM (m)，10\xM (n), or 50|liM ( o ) PA for 24 hours. Serum-deprived L6 
GLUT4myc myotubes were stimulated with lOOnM insulin for 10 min at 37'C, 
followed by fixation. Cells were stained for GLUT4myc as described in Ch. 3 
Materials and Methods. Cells were examined in 400X magnification and the 
white arrows in the images indicated the GLUT4myc. The images are 
representatives of at least three experiments. 
Fig. 9 Effect of OA, LA and PA preincubations in 
insulin-stimulated membrane-intact L6 myotubes 
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Table.4 Effect of Glucose and Insulin preincubation on glucose uptake. L6 
myotubes were preincubated with glucose and insulin for 24 hours. Serum-
deprived L6 GLUT4myc myotubes were stimulated with lOOnM insulin for 30 min 
at 37°C and were rinsed with HEPES-buffered saline solution. Glucose uptake was 
determined as described in Ch. 3 Materials and Methods. All glucose uptake values 
were expressed in relative units relative to the basal carrier-control conditions. 
Results shown are combined means ± SEM from 3 to 9 experiments. A graphic 
presentation of glucose uptake was shown on the bottom of the table. *, p < 0.005; 
**，p < 0.0001 insulin-treated compared with respective basal uptake values. #，p < 
0.0001 folds of increase of glucose uptake preincubated in glucose and insulin 
compared with control. 
Table 4. Effect of Glucose and Insulin 
Preincubation on Glucose Uptake 
n Basal Insulin Ratio % Reduction 
— INS/Ba^ 
Control 9.00 1.00 ±0.00 2.04±0"!i 2.04 -
G25Id25 4.00 1.40 ±0.06 2.25 ±0.17 1.61 41.83 一 
G25In50 5.00 2.08 ±0.l5" 1.55 46.89 ~ 
G25In75 3.00 T^±0.02 2.37 ±0.^ 1.42 59.52 — 
G25Inl00 4.00 11.74 ±0.0912.21 ±0.13 1.27 • 74.40 
^ 3.50 #-
^ CD I 
口 c 3.00 一 ~ — - — — 
s I 
I ^ 2.50 ——^ ^ ^ **一― 
miMm 
Control G25In25 G25In50 G25In75 G25Inl00 
*，p < 0.005; **，p < 0.0001 insulin-treated compared with respective basal uptake values. 
#，p < 0.0001 folds of increase of glucose uptake preincubated in glucose and insulin compared with 
control. 
respectively. The overall glucose uptake after preincubations was 1.61-fold 
compared with 2.04-fold in control cells. Preincubation with high insulin and 
glucose mostly affects the basal glucose uptakes. The basal uptakes at 25mM 
glucose and 50nM, 75nM or lOOnM insulin were 134 士 5%，167 土 2% or 174 士 9%. 
Meanwhile, the respective insulin-stimulated uptakes were 208 士 10%，237 土 9% or 
221 土 13%. Consequently, insulin caused a 1.27-fold increase of glucose uptake in 
cells in high glucose and high insulin relative to the basal value of the stimulated cells 
compared with 2.04-fold in control cells. Hence, the high glucose (25mM) and high 
insulin (lOOnM) preincubation diminished insulin-mediated glucose uptake by 74.4 土 
10.9%, (p = 0.00001). 
3.3.3 TEM study 
3.3.3.1 Effect of high insulin and high glucose incubation in L6 myotubes 
L6 myotubes were preincubated with insulin (lOOnM) and glucose (25mM) for 24 
hours and stimulated with insulin (lOOnM, 10 min). By comparing with controls, 
there were reductions in insulin-induced colocalization of GLUT4myc with actins (fig. 
10b). 
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Fig.lO High glucose and high insulin preincubation on actin cytoskeleton and 
GLUT4 translocation in insulin-stimualted L6 myotubes (TEM). L6 myotubes 
were left untreated (a) or preincubated with 25mM glucose and lOOnM (b) or 
with EtOH for 24 hours. Serum-deprived L6 GLUT4myc myotubes were 
stimulated with lOOnM insulin for 10 min at 37°C，followed by fixation and 
permeabilization. Cells were stained for actin (12nm immunogold) and 
GLUT4myc (18nm immunogold) as described in Ch. 3 Materials and Methods. 
Images were examined in 30000X magnification. The “ indicated the actin 
structure whereas the 牛 represented the GLUT4myc. 
Fig.10 Effect of preincubation on actin and 
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Fig.lO CHO and FFA preincubation on actin cytoskeleton and GLUT4 
translocation in insulin-stimualted L6 myotubes. L6 myotubes were 
preincubated with EtOH and SOfiM CHO (c) or with cyclodextrin and SOfiM OA 
(d) for 24 hours. Serum-deprived L6 GLUT4myc myotubes were stimulated 
with lOOnM insulin for 10 min at 37°C, followed by fixation and 
permeabilization. Cells were stained for actin (12nm immunogold) and 
GLUT4myc (18nm immunogold) as described in Ch. 3 Materials and Methods. 
Images were examined in 30000X magnMcation. The “ indicated the actin 
structure whereas the 令 represented the GLUT4myc. 
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Fig.lO FFA preincubation on actin cytoskeleton and GLUT4 translocation in 
insulin-stimualted L6 myotubes. L6 myotubes were preincubated with 
cyclodextrin and 50[iM LA (e) or with MeOH and 50[iM PA (f) for 24 hours. 
Serum-deprived L6 GLUT4myc myotubes were stimulated with lOOnM insulin 
for 10 min at 37°C, followed by tixation and permeabilization. Cells were 
stained for actin (12nm immunogold) and GLUT4myc (18nm immunogold) as 
described in Ch. 3 Materials and Methods. Images were examined in 30000X 
magnification. The “ indicated the actin structure whereas the • represented 
the GLUT4myc. 
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3.4 Effect of FFA incubation in L6 myotubes 
Increased plasma FFA concentrations are associated with many insulin resistant 
conditions including obesity and Type II DM. Thus, we incubated FFA in L6 
myotubes and examined its effect on actin remodeling and glucose uptake. 
3.4.1 Immunofluorescence Microscopy 
3.4.1.1 FFA incubation in permeabilized L6 myotubes 
To determine the relationship between actin and GLUT4myc after preincuabtion, L6 
myotubes were left untreated, or preincubated with OA (fig. 11), LA (fig. 12) or PA 
(fig. 13) (up to 75|iM) for 24 hours. There were dose-dependent reductions in 
insulin-stimulated actin reorganization when compared with their respective controls. 
The cell growth in low FFA was normal. However, as the FFA concentration 
increased above 20|iM for OA and LA and above 40|iM for PA, cells appeared to be 
narrower and fusions to myotubes were also reduced. When basal cells preincubated 
with FFA were viewed under IM, the myotubes were shorter and slender compared 
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Fig. 11 OA preincubation on actin cytoskeleton in permeabilized L6 myotubes. 
L6 myotubes were preincubated with cyclodextrin and OpAI (a), 20|iM (b), 30^M 
(c), 40^M (d) or SOjiM (e) OA for 24 hours. Serum-deprived 1.6 GIA T4niyc 
myotubes were stimulated with lOOn.M iasulin for 10 min at 37*C\ followed by 
fixation and permeabilization. Cells were stained for actin a^ s described in Ch. 3 
Materials and Methods. The cells wen? examined in 4(M)\ magnificatiun and 
the white arrows in the images indicated the actin structures. I he iunices an* 
representatives* of at least thrci* expcriineiiLs. 
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Fig.l2 LA preincubation on actin cytoskeleton in permeabilized L6 myotubes. 
L6 myotubes were preincubated with cyclodextrin and O^M (a), 20|iM (b)，30\xM 
(c), 40jxM (d)，or SO i^M (e) LA for 24 hours. Serum-deprived L6 GLUT4myc 
myotubes were stimulated with lOOnM insulin for 10 min at 37�C，followed by 
fixation and permeabilization. Cells were stained for actin as described in Ch. 3 
Materials and Methods. The cells were examined in 400X magnification and 
the white arrows in the images indicated the actin structures. The images are 
representatives of at least three experiments. 
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Fig.l3 PA preincubation on actin cytoskeleton in permeabilized L6 myotubes. 
L6 myotubes were preincubated with MeOH and 0 | l i M (a), 2 0 [ i M (b)，50[iM (c)， 
60mM (d)，or 75fiM (e) PA for 24 hours. Serum-deprived L6 GLUT4myc 
myotubes were stimulated with lOOnM insulin for 10 min at 37�C，followed by 
fixation and permeabilization. Cells were stained for actin as described in Ch. 3 
Materials and Methods. The cells were examined in 400X magnification and 
the white arrows in the images indicated the actin structures. The images are 
representatives of at least three experiments. 
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with control myotubes. Aberrant insulin-stimulated actin mesh formation was 
observed in cells preincubated with FFA. These actin aggregations in the stimulated 
cells were shorten in length and were broken into small fragments. At the high 
levels of OA, LA and PA preincubations (SOjiM), actin remodeling was significantly 
diminished by 46.2%, (p < 0.005), 51.0%, (p < 0.0005), and 37.6%, (p < 0.0001)， 
respectively (table. 2c and 2d). 
3.4.1.2 FFA incubation in membrane-intact L6 myotubes 
To determine translocation of GLUT4myc after preincubation, L6 myotubes were 
incubated with cyclodextrin and OA, LA or MeOH and PA for 24 hours (fig. 9). The 
morphological changes during cell growth were similar to basal permeabilized cells 
preincubated with FFA. When basal cells preincubated in FFA were viewed under 
IM, no GLUT4myc was visible. Insulin stimulation caused the translocation of 
GLUT4myc to the PM. By comparing with their respective controls, there were 
reductions in insulin-induced recruitment of GLUT4myc. 
3.4.2 2-Deoxyglucose Uptake 
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3.4.2.1 FFA incubation in L6 myotubes (24 hours) 
To determine the effect of preincubation on glucose uptake, L6 myotubes were 
exposed to FFA for 24 hours. The reductions in insulin-mediated glucose uptake 
were dose-dependent at concentrations between 20 to 75^iM of FFA. All uptake 
values were compared with basal control glucose uptake. 
The responses of unsaturated fatty acids - OA preincubation was shown on table 5. 
Insulin stimulated glucose uptake from 100 ± 0% to 185 士 1% in 
methyl-P-cyclodextrins-control L6 myotubes. The basal uptakes at 20|^M, 30|iM, 
40|iM or 50jiM OA were 140 土 14%, 150 土 11%, 143 土 7% or 168 土 4%. 
Meanwhile, the respective insulin-stimulated uptakes were 261 土 23%, 259 士 19%, 
224 土 9% or 228 土 5%. A 24 hours OA preincubation (50|iM) increased basal and 
insulin-stimulated uptake to 168 土 4% and 228 土 5% respectively. High levels of 
OA (50|iM) for 24 hours diminished glucose uptake by 45.8 土 8.6%，(p = 0.0005). 
Insulin caused 1.36-fold increase in glucose uptakes relative to the basal values of the 
stimulated cells compared with 1.85-fold in methyl-P-cyclodextrins-control. 
The responses of unsaturated fatty acids - LA preincubation was shown on table 6. 
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Table.5 Effect of OA preincubation on glucose uptake. L6 myotubes were 
preincubated with cyclodextrin and OA for 24 hours. Serum-deprived L6 
GLUT4myc myotubes were stimulated with lOOnM insulin for 30 min at 37°C and 
were rinsed with HEPES-buffered saline solution. Glucose uptake was immediately 
determined as described in Ch. 3 Materials and Methods. All glucose uptake values 
were expressed in relative units relative to the basal cyclodextrin-control conditions. 
Results shown are combined means 土 SEM from 5 to 13 experiments. A graphic 
presentation of glucose uptake was shown on the bottom of the table. *，p < 0.01; **, 
p < 0.001 insulin-treated compared with respective basal uptake values. #，p < 
0.0001 folds of increase of glucose uptake preincubated in OA compared with 
cyclodextrin-control. 
Table 8. Effect of CHO Preincubation on Glucose 
Uptake 
n Basal Insulin Ratio % Reduction 
- — I N S / B ^ 
CycloSOO 13.00 1.00 ±0.00 T^5±0.01 1.85 -
OA20 5.00 1.40 ±0.14 2.61 ±0.23 1.87 2.59 _ 
OA30 6.00 1.50 ±0.11 2.59 ±0.19 1.72 14.88 
OA40 6.00 一1.43±0.07 了24±0.09 1.57 33.14 
OA50 9.00 I 1.68 ±0.04 12.36 ±0.05 1.41 51.83 
3.50 1 TT  
# 
^ 3.00 * 
M <L> T 
C^ O T 
^ a J 
口 器 2.50 ^ t a ^  
i M i l j 
CycloSOO OA20 OA30 OA40 OA50 
*，p < 0.01; **，p < 0.001 insulin-treated compared with respective basal uptake values. 
#，p < 0.0001 folds of increase of glucose uptake preincubated in OA compared with cyclodextrin-control. 
5a 
Table.6 Effect of LA preincubation on glucose uptake. L6 myotubes were 
preincubated with cyclodextrin and LA for 24 hours. Serum-deprived L6 
GLUT4myc myotubes were stimulated with lOOnM insulin for 30 min at 37�C and 
were rinsed with HEPES-buffered saline solution. Glucose uptake was determined 
as described in Ch. 3 Materials and Methods. All glucose uptake values were 
expressed in relative units relative to the basal cyclodextrin-control conditions. 
Results shown are combined means ± SEM from 4 to 9 experiments. A graphic 
presentation of glucose uptake was shown on the bottom of the table. *，p < 0.01; **, 
p < 0.0001 insulin-treated compared with respective basal uptake values. #，p < 
0.001 folds of increase of glucose uptake preincubated in LA compared with 
cyclodextrin-control. 
Table 6. Effect of LA Preincubation on Glucose 
Uptake 
n Basal Insulin Ratio % Reduction 
INS/Basal  
CycloSOO 9.00 1.00 ±0.00 1.87 ±0.03 1.87 “ -
LA20 — 6.00 1.18 ±0.04 2.25 ± 0 ^ 1.90 3.16 
LA30 5.00 1.54 ±0.11 2.26 ±0.10 1.47 — 45.84 _  
LA40 - 4.00 1 7 2 ±0.16 2.00 1.41 53.54 一 
LA50 8.00 I 1.64 ±0.04 I 1.39 57.09 
3.50 n —. 
二它 
f-H 3»00 ~ ------- - - ._._.— _—._ — — — - — — --.-. — — —•— 
Q 2 50 ** -*—* _ •• 
miMw 
Cyclo500 LA20 LA30 LA40 LA50 
*, p < 0.01; **，p < 0.0001 insulin-treated compared with respective basal uptake values. 
#, p < 0.001 folds of increase of glucose uptake preincubated in LA compared with cyclodextrin-control. 
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Insulin stimulated glucose uptake from 100 ± 0 % to 187 土 3% in 
methyl-p-cyclodextrins-control L6 myotubes. The basal uptakes at 20|aM, 30|iM, 
40jiM or 50|iM LA were 118 土 4%，154 土 11%，142 土 16% or 164 土 4%. 
Meanwhile, the respective insulin-stimulated uptakes were 214 士 6%，226 ± 10%, 200 
土 20% or 228 ± 5 % . A 24 hours LA preincubation (50|aM) increased basal and 
insulin-stimulated uptake to 164 土 4% and 228 士 5% respectively. High levels of LA 
(50|iM) for 24 hours diminished glucose uptake by 57.1 土 8.5%, (p = 0.004). 
Insulin caused 1.39-fold increases in glucose uptakes relative to the basal values of 
the stimulated cells compared with 1.87-fold in methyl-P-cyclodextrins-control. 
The responses of saturated fatty acid - PA preincubation was shown on table 7. 
Insulin stimulated glucose uptake from 100 土 0% to 196 土 1% in MeOH-control L6 
myotubes. The basal uptakes at 20|iM, 40jaM, 50|iM, 60j^M or 75|iM PA were 98 土 
4%, 100 土 2%, 124 土 2%，136 土 3% or 148 士 12%. Meanwhile, the respective 
insulin-stimulated uptakes were 196 土 7%, 193 土 5，206 土 3%，221 土 7% or 242 土 
24%. A 24 hours PA preincubation (50|iM) increased basal and insulin-stimulated 
uptake to 124 土 2% and 206 士 3% respectively. Exposure of 50|iM PA caused a 33.3 
土 8.8%，(p = 0.0008) reduction in glucose uptake. Insulin stimulated glucose uptake 
was 1.63-fold higher than the basal values of the stimulated cells compared with 
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Table.7 Effect of PA preincubation on glucose uptake. L6 myotubes were 
preincubated with MeOH and PA for 24 hours. Serum-deprived L6 GLUT4myc 
myotubes were stimulated with lOOnM insulin for 30 min at 37°C and were rinsed 
with HEPES-buffered saline solution. Glucose uptake was determined as described 
in Ch. 3 Materials and Methods. All glucose uptake values were expressed in 
relative units relative to the basal MeOH-control conditions. Results shown are 
combined means ± SEM from 3 to 13 experiments. A graphic presentation of 
glucose uptake was shown on the bottom of the table. *, p < 0.05; **, p < 0,001 
insulin-treated compared with respective basal uptake values. #，p < 0.0001 folds of 
increase of glucose uptake preincubated in PA compared with MeOH-control. 
/ 
Table 8. Effect of CHO Preincubation on Glucose 
Uptake 
n Basal Insulin Ratio % Reduction 
INS/Basal 
MeOH0.16^ 13.0 “ 1.00±0.00 _ 1.96±0.01 1.96 — -
PA 20 5.0 0.98 ±0.04 1.96 ±0.07 — 2.01 4.65 
PA 40 6.0 0.97 ±0.02 1.87 ±0.04 1.94 _ 2.74 
PA 50 10.0 - 1.24 ±0.02 - 2.06 ±0.03 1.67 33.30 
PA 60 5.0 “ 1.31 ±0.03 -2.21 ±0.07 1.63 — 34.44 
PA 75 3.0 1.36 ±0.06 2.42 ±0.24 1.65 32.19 
O M 
s S 3 . 5 0 — — — . 
o f 3.00 - ^ ― 
2 50 — — “— — ~ — — — — 
_|誦:_ 
一 MeOH 0.165% PA 20 PA 40 PA 50 PA 60 PA 75 
*, p < 0.05; **，p < 0.001 insulin-treated compared with respective basal uptake values. 
#，p < 0.0001 folds of increase of glucose uptake preincubated in PA compared with MeOH-control. 
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1.96-fold in MeOH-control. 
3.4.3 TEM study 
3.4.3.1 FFA incubation in L6 myotubes 
L6 myotubes were preincubated with cyclodextrins and SO^M OA (fig. lOd), 50jiM 
LA (fig. lOe) or with MeOH and 50|LIM PA (fig, lOf) for 24 hours. By comparing 
with controls, there were reductions in insulin-induced colocalization of GLUT4myc 
with actins. 
3.5 Effect of CHO incubation in L6 myotubes 
Elevated serum total CHO level is commonly found in patients with diabetes. Thus, 
we preincubated CHO in L6 myotubes and examined its effect on actin remodeling 
and glucose uptake. 
3.5.1 Immunofluorescence Microscopy 
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3.5.1.1 CHO incubation in permeabilized L6 myotubes 
To determine the relationship between actin and GLUT4myc after preincuabtion, L6 
myotubes were left untreated, or preincubated with CHO (up to 50|liM) for 24 hours 
(fig. 14). There were dose-dependent reductions in insulin-stimulated actin 
reorganization when compared with EtOH controls. The cell growth in low CHO 
was normal. However, as the CHO concentration increased above 20|iM, cells 
appeared to be narrower and fusions to myotubes were also reduced. When basal 
cells preincubated with CHO were viewed under IM, the myotubes were shorter and 
slender compared with control myotubes. Aberrant insulin-stimulated actin mesh 
formation was observed in cells preincubated in CHO. These actin aggregations in 
the stimulated cells were shorten in length and were broken into small fragments. 
High levels of CHO preincubation (50)iM) caused a 53.0%, (p < 0.0005) reduction in 
actin remodeling (table. 2b). 
3.5.1.2 CHO incubation in membrane-intact L6 myotubes 
To determine translocation of GLUT4myc after preincubation, L6 myotubes were left 
untreated, or treated with EtOH and CHO at 0)iM (fig. 9d), \0[iM (fig. 9e), or 50|iM 
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Fig.l4 CHO preincubation on actin cytoskeleton in permeabilized L6 
myotubes. L6 myotubes were preincubated with EtOH and OjnM (a), lO i^M (b)， 
2Q\m (c)，30^M (d)，40\M (e)，or 50|jM (f) CHO for 24 hours. Serum-deprived 
L6 GLUT4myc myotubes were stimulated with lOOnM insulin for 10 min at 37�C， 
followed by fixation and permeabilization. Cells were stained for actin as 
described in Ch. 3 Materials and Methods. The cells were examined in 400X 
magnification and the white arrows in the images indicated the actin structures. 
The images are representatives of at least three experiments. 
Fig.14 CHO preincubation on actin cytoskeleton 
in permeabilized L6 myotubes 
O^ M CHO lO^M CHO 
• • 
20nM CHO 30^M CHO  
40^M CHO 50nM CHO 
mm 
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(fig. 9f) for 24 hours. The morphological changes during cell growth were similar to 
basal permeabilized cells preincubated with CHO. When basal cells preincubated 
with CHO were viewed under IM, no GLUT4myc was visible. Insulin stimulation 
caused the translocation of GLUT4myc to the PM. By comparing with their 
respective controls, there were reductions in insulin-induced recruitment of 
GLUT4myc. 
3.5.2 2-Deoxyglucose Uptake 
3.5.2.1 CHO incubation in L6 myotubes (24 hours) 
To determine the effect of preincubation on glucose uptake, L6 myotubes were 
exposed to CHO for 24 hours. All uptake values were relative to basal EtOH-control 
glucose uptake. Chronic exposure of L6 myotubes to CHO reduced the insulin 
stimulated glucose uptake significantly. The effects of insulin on glucose uptake 
were dose-dependent at concentrations between 10 to 60|iM of CHO (table 8). 
Insulin stimulated glucose uptake from 100 土 0% to 193 土 1%. The basal uptakes 
at 20|iM, 30|^M, 40}iM, 50|iM or 60|iM CHO were 70 土 0%, 82 士 6%, 143 土 5%, 141 
± 3% or 200 ±25%. Meanwhile, the respective insulin-stimulated uptakes were 127 
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Table.8 Effect of CHO preincubation on glucose uptake. L6 myotubes were 
preincubated with EtOH and CHO for 24 hours. Serum-deprived L6 GLUT4myc 
myotubes were stimulated with lOOnM insulin for 30 min at 37"C and were rinsed 
with HEPES-buffered saline solution. Glucose uptake was determined as described 
in Ch. 3 Materials and Methods. All glucose uptake values were expressed in 
relative units relative to the basal EtOH-control conditions. Results shown are 
combined means ± SEM from 3 to 7 experiments. A graphic presentation of glucose 
uptake was shown on the bottom of the table. *，p < 0.01; **，p < 0.005 insulin-
treated compared with respective basal uptake values. #, p < 0.0001 folds of 
increase of glucose uptake preincubated in CHO compared with EtOH-control. 
Table 8. Effect of CHO Preincubation on Glucose 
Uptake 
n Basal Insulin Ratio % Reduction 
INS/Basal ~ 
EtOH 0.5% 7.00 1.00 ±0.00 —1.93 ±0.01 1.93 — -
CH020 一 3.00 0.70 ±0.00 _1.27±0.00 — 1.82 11.53 
CH030_ 3.00 0.82 ±0.06 1.47 ±0.10 — 1.80 — 14.30  
CH040 4.00 1.43 ±0.05 2.04 ±0.05 — 1.43 53.69 
C H 0 5 0 _ 5.00 l 4 1 ± 0 . 0 3 _ 1 . 9 7 ± 0 . 0 4 1.40 ~ 56.70 
CH060 3.00 2.00 ±0.25 2.72 ±0.40 1.36 61.72 
3.50 
^ # 
3.00 - T 
D 8 
2 I 2.50 - • 
mMMW 
EtOH 0.5% CH020 CH030 CH040 CH050 CH060 
*, p < 0.01; **，p < 0.005 insulin-treated compared with respective basal uptake values. 
#，p < 0.0001 folds of increase of glucose uptake preincubated in CHO compared with EtOH-control. 
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土 0%，147 土 10%，204 土 5%，197 士 4% or 272 土 40%. A 24 hours CHO 
preincubation (SOjiM) increased basal and insulin-stimulated uptake to 141 ± 3 % and 
197 士 4% respectively. Preincubation with high CHO (50jiM) reduced the glucose 
uptake by 56.7 ±8.5%, (p = 0.0005). Insulin caused a 1.36-fold increase in glucose 
uptake relative to the basal value of the stimulated cells compared with 1.93-fold in 
EtOH-control. 
3.5.3 TEM study 
3.5.3.1 CHO incubation in L6 myotubes 
L6 myotubes were incubated with CHO (50|iM) for 24 hours and stimulated with 
insulin (lOOnM, 10 min). By comparing with controls, there were reductions in 
insulin-induced colocalization of GLUT4myc with actins (fig. 10c) 
3.6 Overall changes in glucose uptake after preincubation experiment 
From the experiments of preincubating L6 myotubes in conditions stimulating insulin 
resistance, a common characteristic of increasing basal glucose uptake was observed 
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(table 9). Basal uptake values from stimulated cells were compared with values 
from control or carrier-control cells. In the high glucose and high insulin study, 
25mM glucose and lOOnM insulin preincubation increased the basal glucose uptake 
by 73.9 士 3.0% when compared with control cells. Besides, the basal glucose 
uptakes for OA, LA and PA (50jiM) compared with their respective basal 
carrier-control values increased by 64.4 土 5.6%, 62.1 土 2.0% and 28.1 土 2.3% 
respectively. In addition, high CHO (50|aM) preincubation caused a 40.7 土 3.2% 
increase in basal glucose uptake. 
Following incubations with various conditions mimicking insulin resistance, the 
insulin-stimulated glucose uptake was also increase, but to a lesser extent as 
compared to the increase in basal glucose uptake (table 9). Insulin-stimulated uptake 
values from stimulated cells were compared with values from control or 
carrier-control cells. In the 25mM glucose and lOOnM insulin experiment, the 
insulin-stimulated glucose uptake increased by 5.82 土 2.2% when compared with 
control L6 myotubes. Besides, the insulin-stimulated glucose uptakes for OA, LA 
and PA (50}iM) compared with insulin-stimulated carrier-control values increased 
29.7 土 3.0%, 19.3 土 3.1% and 7.47 土 2.5% respectively. In addition, high CHO 
(50|iM) preincubation increased 1.87 土 1.5% in insulin-stimulated glucose uptake. 
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Table.9 Percentage of increase on glucose uptakes compared with carrier-
control cells before and after insulin treatment. Cells were preincubated with 
glucose and insulin, FFA or CHO and glucose uptakes were determined as 
described in Ch. 3 Materials and Methods. Results shown are combined means ± 
SEM. All values were determined by comparing the basal or insulin-stimulated 
uptake of the preincubated cells with their respective basal or insulin-stimulated 







































































































































































Consequently, the folds of increase in insulin-mediated glucose uptake were 
significantly reduced following preincubation with various FFA, CHO or high insulin 
and glucose conditions. 
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CHAPTER FOUR DISCUSSION 
The purpose of our study is to elucidate the effect of insulin-stimulated actin 
reorganization on insulin-mediated GLUT4 translocation and glucose uptake. 
Previous studies have shown the importance of actin remodeling on these two issues. 
Disrupting of actin ruffles induces a form of insulin resistance to L6 myotubes and the 
same mechanism may also apply to the state of insulin resistance in general. Thus, 
we preincubated cells in conditions associated with insulin resistance and examined 
their effects on insulin-mediated actin reorganization and glucose uptake. We 
hypothesize that the defect of glucose uptake in the state of insulin resistance is a 
combined effects of abnormal GLUT expression and activities, aberrant insulin signal 
propagation and interference with actin accessory proteins. Preincubating cells in 
the conditions of insulin resistance may affect the normal signal propagation and 
avoid the initiation of actin reorganization. There are increasing evidences showing 
that a correlative relationship between actin reorganization and GLUT4 translocation 
exists. The insulin-induced GLUT4 translocation and activation may be depended 
on an intact actin network and insulin-stimulated actin reorganization. The newly 
formed actin network may allow correct sequential activations in insulin signaling 
pathway by distributing the signaling molecules to proper locations. In addition, 
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actin reorganization and membrane ruffling formation may also directly participate in 
the translocation of GLUT4. Nowadays, despite of numerous researches, the 
pathology of insulin resistance is still unclear. Since actin disassembly abolishes 
GLUT4 translocation and creates a form of resistance to insulin, aberrant GLUT4 
translocation caused by actin disruption affects glucose homeostasis and may 
contribute to insulin resistance in general. 
4.1 Effect of insulin on L6 myotubes 
The ability of insulin to stimulate glucose uptake in L6 myotubes has been 
demonstrated for many years. In 2-Deoxyglucose uptake experiments, insulin 
causes a 2.00-fold increase in glucose uptakes relative to the basal values of the 
control cells {Klip, Logan, et al. 1982}. This is similar to the insulin-stimulated 
glucose uptake value of 1.89-fold reported from our study. In addition, stimulation 
of glucose uptake by insulin is observed within a few minutes and remains constant 
for at least an hour {Klip, Li, et al. 1984}. We have demonstrated a similar effect by 
incubating cells in 5 and 10 min of 2-Deoxyglucose. Both treatments yield similar 
ratios between insulin-stimulated and basal glucose uptakes. 
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In addition to act as an anabolic hormone with powerful metabolic and mitogenic 
effects, insulin also induces actin reorganization that leads to the formation of 
membrane ruffles {Tsakiridis, Vranic, et al. 1994}. We have examined the time 
(fig. 2) and concentration (fig. 3) course of insulin addition to L6 myotubes. Under 
the basal state, actin filaments were expressed as long actin microfilament bundles of 
variable length and thickness that could be detected throughout the cell. Insulin 
stimulation elicited a dramatic reorganization of actin filaments in serum-deprived L6 
myotubes. The length of the actin aggregations increased through time and was the 
most pronounced at 10 min of insulin treatment. On the other hand, a concentration 
profile was constructed from 0 to 6000nM of insulin. Results showed that there was 
a positive correlation between concentration of insulin and degree of actin 
reorganization. Noticed the increased insulin concentration caused an increase in the 
magnitude of actin remodeling. However, an inhibiting effect was observed above 
lOOOnM of insulin. The newly formed insulin-induced actin structure appeared to 
scatter into small fragments and distribute unevenly on the surface of the myotubes. 
Nonetheless, the addition of lOOnM insulin produced a good effect on actin 
remodeling, and is same concentration used in other studies used {Khayat, Tong, et al. 
2000}. Thus, we have chosen the optimal time and concentration of insulin usage 
for our study of actin reorganization to be 10 min and lOOnM. 
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Upon the stimulation of insulin, GLUT4 located in the intracellular compartment 
translocate to the PM and promote glucose uptake. Several studies have shown the 
importance of actin remodeling in the translocation of GLUT4. First of all, CD, a 
widely used inhibitor of actin filament formation, inhibits actin reorganization and 
glucose uptake {Tsakiridis, Vranic, et al. 1994}. Another study from Tong has 
revealed the colocalization of GLUT4 with actin structures from the ventral to the 
dorsal surface after insulin stimulation. Besides, Jasplakinolide, drug that affects 
actin filament stability, reduces GLUT4 appearance at the cell surface after insulin 
treatment {Tong, Khayat, et al. 2001}. Indeed, our findings are consistent with their 
observations (fig. 4). The presence of an exofacial c-myc epitope tag on GLUT4 
allows us to track the cellular GLUT4myc in permeabilized and membrane-intact 
cells. Under the basal state of permeabilized L6 myotubes, actin bundles were 
aligned longitudinally along the cells. Meanwhile, GLUT4myc appeared in clusters 
were mostly concentrated around the myonuclei. Insulin stimulation caused actin 
filament reorganization throughout the cells. GLUT4myc were also found to begin 
localizing with the actin structure. GLUT4myc have been reported to become more 
condensed and colocalized in the ruffles after 30 min of insulin treatment {Khayat, 
Tong, et al. 2000}. Interestingly, only a small portion of GLUT4myc translocated 
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with the actin structures where there was still a large portion of GLUT4myc remained 
in the intracellular compartments. Previous study from Shepherd et al supported our 
observation {Shepherd & Kahn 1999}. They suggested that there are about 10% of 
GLUT4 located on the PM at the basal state. Insulin mobilizes GLUT4 to attain a 
new equilibrium state that about 30% is now inserted on PM. Cell surface 
immunostainings were carried out in membrane-intact L6 myotubes (fig. 5). Under 
the basal state, no GLUT4myc was visible. After the 10-minute insulin treatment, 
GLUT4myc were observed on PM. 
In conclusion, through the results of our IM study, insulin stimulates the 
reorganization of actin filaments into actin aggregations. These actin networks may 
facilitate the insertion of GLUT4 to the PM and thereby induce glucose uptake. The 
actin structures may tether the necessary signaling molecules in proper positions for 
effective phosphorylation and signal transduction down the pathway. 
In order to obtain a more accurate idea of insulin-mediated glucose uptake in relation 
to actin and GLUT4, we performed TEM using immunogold labeling of actin and 
GLUT4myc. In our knowledge we are the first group to investigate the translocation 
of GLUT4 with actin using the technique of TEM. Indeed, we have achieved direct 
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evidences of actin remodeling and GLUT4 colocalization (fig. 7). In basal condition 
of L6 myotubes, actins were mostly found along the stress fibers whereas GLUT4myc 
were located near the nuclei. It was rare for GLUT4myc to locate near the PM or 
colocalize with actin particles. The 10-minute insulin stimulation revealed the 
colocalization of GLUT4myc with actin structures. In some events we were able to 
directly observe the structures of actin remodeling as a finger-liked protrusion from 
PM. Noticed both actin and GLUT4myc gold particles were found in the protrusion. 
Most importantly, these structures can only be found in the insulin-stimulated L6 
myotubes. 
Our TEM procedure is a novel technique for sample grown from cell culture. We 
have to modify the standard procedure to suit the nature of L6 myotubes and our 
study purpose. The problem of TEM is that the final sample condition is quite 
unpredictable. After insulin stimulation of L6 myotubes, samples have undergone 
numerous tentative procedures including cell fixation, dehydration, scrapping, slicing 
and staining before they are ready to be observed under the microscope. Hence, 
there are a lot of possible sites for discrepancy to occur. The most probably site will 
be the slicing process. Since the sample is sliced, cellular structures are 
unpreventably damaged or even destroyed. This may seriously affect the illustration 
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of fragile structures such as the insulin-induced actin protrusion. In addition, cells 
are scrapped and centrifuged before they are embedded for polymerization. Thus, it 
is highly unlikely that the cell surfaces in the embedded block are facing the same 
direction, which is found in the case of IM. However, TEM cell samples may be 
facing all possible directions when they are sliced. As a result, we have actually no 
control on how cells are located on the ultrathin section. The unpredictable slicing 
may seriously affect their cellular outlooks in TEM photos. 
Another problem we encounter with TEM is the low antibody staining. Unlike in 
the case of IM where samples are seeded on the surface of a cover slide and have 
equal assess to antibody staining, TEM sections are mounted on formver-coated 
nickel grids. The formver mounting may limit the antibody contact with the cells. 
Besides, tentative TEM procedure may also affect the conditions of antigen sites. 
There are several possible explanations for the loss of staining: (1) Cross-linking 
fixation by PFA and glutaraldehyde may mask or even destroy the necessary antigen 
sites for antibody binding; (2) Resin polymerization at high temperature or the use of 
propylene oxide may damage the antigen sites; (3) Secondary immunogold binding to 
antigen sites may be blocked by primary immunogold particles during sequential 
double staining. Hence, we carried out numerous experiments to optimize the 
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labeling procedure. With all these conditions, the interpretation of TEM imaging 
should be cautious. The images presented in this thesis represent the typical findings 
of at least 3 to 5 experiments. This procedure was adopted to ensure consistency in 
the spotting of the TEM results. 
4.2 Effect of methyl-p-cyclodextrins, MeOH and EtOH on L6 myotubes 
Due to the low solubilities in aqueous solutions, lipids and CHO are either 
predissolved in organic solvents or accompanied with carrier molecules to facilitate 
their dissolutions. Both OA and LA purchased were accompanied with 
methyl-P-cyclodextrins whereas PA and CHO were predissolved in MeOH and EtOH 
respectively. The effect of methyl-P-cyclodextrins, MeOH or EtOH alone on actin 
and GLUT4 was negligible for permeabilized or membrane-intact L6 myotubes (table 
2 and fig. 6). Besides, the addition of methyl-p-cyclodextrins, MeOH or EtOH alone 
with insulin stimulation caused an insignificant reduction in glucose uptake (table 3). 
Thus, the incubation of methyl-P-cyclodextrins, MeOH or EtOH had no effect on 
actin reorganization and glucose uptake in L6 myotubes. For accurate comparison, 
all glucose uptakes in control and preincubation experiments are expressed in relative 
units relative to the basal control or their respective basal carrier-containing glucose 
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uptake values. 
4.3 Effect of pretreatment of cells in conditions of insulin resistance 
Insulin resistance, the ineffectiveness of insulin to stimulate glucose uptake, is a major 
characteristics of Type II DM and obesity. Although insulin resistance is well 
characterized, the exact mechanism remains unclear. Patients with diabetes normally 
have hyperglycemia and hyperinsulinemia. Increased plasma FFA and total serum 
cholesterol levels are also common in diabetics. As a result, we preincubated cells in 
the conditions similar to those found in insulin resistance and studied their effects on 
actin reorganization and glucose uptake. 
4.3.1 Effect of high glucose and high insulin preincubation on L6 myotubes 
To understanding the effect of hyperglycemia and hyperinsulinemia on glucose uptake, 
cells were incubated with insulin and glucose for 24 hours. Dose-dependent 
reductions of actin remodeling and glucose uptake were observed. Results from our 
study showed that preincubation with high glucose (25mM) and high insulin (lOOnM) 
levels significantly reduced glucose uptake (table 4). Our results are consistent with 
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previous observations. A 10-hour preincubation with high insulin alone has been 
reported to increase basal and decrease acute insulin-stimulated glucose uptake in 
3T3-L1 adipocytes {Ricort, Tanti, et al. 1995}. Besides, 3T3-L1 adipocytes treated 
with insulin for 18 hours demonstrated elevated basal but minimal insulin-stimulated 
glucose uptake {Knutson, Donnelly, et al. 1995}. Thus, it is not surprising that our 
24-hour insulin incubation yielded the same conclusion. Meanwhile, preincubation 
with high glucose and low insulin has been found to inhibit basal and acute 
insulin-stimulated glucose uptake relative to control {Nelson, Robinson, et al. 2000}. 
In addition, high glucose and high insulin incubation has been reported to reduce the 
insulin-stimulated glucose uptake by 56% in L6 skeletal muscle cells {Tong, Khayat, 
et al. 2001}. Taken together, chronic glucose and insulin exposure may exert an 
additive effect on glucose uptake. 
IM was carried out to examine the locations of actin reorganization (fig. 8). 
Preincubation with high glucose (25mM) and high insulin (lOOnM) levels reduced 
actin remodeling by 64.7% (table. 2). Moreover, in membrane-intact L6 myotubes, 
by comparing with their respective controls, there were noticable reductions in 
insulin-induced GLUT4myc recruitment in glucose and insulin stimulated cells (fig. 
9). Previous studies have confirmed the same observation. For instance, a similar 
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study of high glucose and high insulin preincubation in L6 myotubes for 24 hours 
shows similar reduction in actin reorganization {Tong, Khayat, et al. 2001}. Besides, 
high glucose and high insulin preincubation also causes a noticeable reduction of 
GLUT4myc recruitment to PM {Tong, Khayat, et al. 2001}. Furthermore, high 
glucose and high insulin preincubation reduces the total amount of myotubes with 
insulin-stimulated actin remodeling by 50%. These actin structures are discrete and 
scattered and are similar to our own findings. Interestingly, the appearance of actin 
structure and reduction in GLUT4myc PM insertions in high glucose and high insulin 
preincubation resembles to those resulted from actin inhibitors such as swinholide-A. 
As a result, both swinholide-A and high glucose and high insulin preincubation may 
affect a similar mechanism. 
4.3.2 Effect of FFA preincubation on L6 myotubes 
Increased plasma FFA concentrations are associated with many insulin resistant 
conditions including obesity and Type II DM {Dresner, Laurent, et al. 1999}. Thus, 
we incubated L6 myotubes with FFA to induce insulin resistance. Preincubation of 
OA (table 5)，LA (table 6) and PA (table 7) for 24 hours all significantly diminished 
glucose uptake. Again, dose-dependent reductions of insulin-mediated glucose 
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uptake were observed. Numerous studies have demonstrated a negative relationship 
between FFA and insulin-stimulated glucose uptake. For example, elevated FFA 
levels caused by a high fat diet {Oakes, Cooney, et al. 1997} or Intralipid and heparin 
infusion {Kim, Seo, et al. 2000} in rats have been shown to decrease 
insulin-stimulated glucose transport. In addition, OA, LA and PA preincubations 
have also been demonstrated separately to reduce insulin-stimulated glucose transport 
in C2C12 skeletal muscle cells {Schmitz-Peiffer, Craig, et al. 1999}. Furthermore, 
Storz and coworkers preincubate pmi28 myotubes with PA and produce the same 
result of decreased insulin-stimulated glucose uptake {Storz, Doppler, et al. 1999}. 
As a result, our findings once again confirmed with their observations. 
Preincubation of OA (fig. 11), LA (fig. 12) and PA (fig. 13) for 24 hours diminished 
insulin-stimulated actin remodeling (table. 2) and GLUT4myc recruitment on PM (fig. 
9) in a dose-dependent manner. Given that unsaturated FFA is able to cause 
abnormal distribution pattern of spectrin organization {Stephen, Yokota, et al. 1990}, 
it is not surprising that FFA preincubation may also alter the actin remodeling. 
Besides, previous study has incubated radiolabeled arachidonic acid (AA), an 
example of polyunsaturated fatty acids and PA on blood platelets. Tight bindings 
between FFA to cytoskeletal structures and a-actinin were found {Bum 1988}. In 
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addition, there is a difference in cytoskeletal binding between the saturated and 
unsaturated fatty acids. Thus, FFA may have the ability to interfere with the 
functioning of actin accessory proteins. Given that actin accessory proteins can 
regulate actin dynamics, together with our results they propose a possible involvement 
of FFA in the assembly of actin filaments. 
Surprisingly, our PA preincubation yielded the lowest reductions in glucose uptake 
and actin remodeling among the choices of FFAs. Previous studies have been 
demonstrated that PA preincubations reduced insulin-stimulated glucose transport in 
C2C12 skeletal muscle cells {Schmitz-Peiffer, Craig, et al. 1999} and pmi28 
myotubes {Storz, Doppler, et al. 1999}. Thus, it has been previously confirmed that 
chronic PA preincubation can reduce glucose uptake. The discrepancy in the degree 
of glucose uptake reduction between saturated and unsaturated FFA may be due to 
altered membrane fluidity, aberrant insulin signal propagation or abnormal actin 
accessory protein function. For example, membrane lipid profile of cultured cells 
can be changed by fatty acid supplements and each FFA has its specific rate of 
membrane incorporation {Spector & Yorek 1985}. These differences may result in 
various membrane lipid profiles that may have distinct actions on glucose transport. 
Meanwhile, prolonged treatment of rat adipocytes with PA has been shown to reduce 
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glucose uptake with only a slight decrease in insulin binding {Hunnicutt, Hardy, et al. 
1994}. A post-insulin binding defect including modified activities in components of 
insulin signal pathway may be presented in these PA-pretreated cells. Furthermore, 
there are also different regulatory actions on actin accessory proteins between various 
FFAs {Bum 1988}. As a result, these could be accounted for the minimal effect of 
PA preincubation on glucose uptake and actin remodeling on L6 myotubes. 
Supplementing the culture medium with specific lipids and CHO can modify the lipid 
content of cultured cell membranes {Spector & Yorek 1985}. The cultured cells 
tend to take up the lipid and CHO available in the medium and cease its own 
endogenous production. As a result, exogenous lipids and CHO will be able to 
incorporate into the cell membrane. However, the incorporation of lipids and CHO 
are different for various lipids and CHO. For example, data from Spector et al has 
shown the different incorporation rates for four different fatty acid supplements 
{Spector & Yorek 1985}. PA supplement only causes a small amount of PA and total 
saturated fatty acid incorporation in cell membrane. This could be the reason that PA 
has less effect on insulin-mediated glucose uptake and actin remodeling in L6 
myotubes. Moreover, supplementing with OA increases the OA content by 60% and 
also a large decrease in the saturated fatty acid content. Another study has proved 
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that there is a difference in lipid incorporation from various lipid supplements in 
HepG2 hepatoma cell. Thus, it is conceivable that the unique response in lipid and 
CHO supplements may induce different membrane incorporation patterns that 
produce various effects on cellular metabolism. This could be the reason for 
different results in the FFA preincubation experiments. Despite of short period of 
incubation time, the preincubation experiments may insert exogenous FFA into the 
membrane and alter normal membrane functioning. For example, actin binding has 
been illustrated to increase membrane permeability and the increased membrane 
permeability is reduced by CHO introduction {Okimasu, Nobori, et al. 1987}. Thus, 
the change in membrane fluidity may affect insulin-mediated glucose uptake. 
4.3.3 Effect of CHO preincubation on L6 myotubes 
Elevated serum total CHO level is commonly found in patients with diabetes. Our 
CHO preincubation experiment may provide insight in explaining the adverse effect 
of CHO on glucose uptake. The CHO preincubation caused dose-dependent 
reductions in insulin-induced glucose uptake (table 8)，actin remodeling (table. 2 and 
fig. 14) and PM recruitment of GLUT4myc (fig. 9). Our results have provided direct 
evidences that high levels of CHO impaired insulin action in skeletal muscle. Indeed, 
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chronic CHO incubation has been demonstrated to alter the organization of actin 
filament in human renal carcinoma cells {Ludes, Schmit, et al. 1993}. In addition, 
introduction of CHO into liposomal membrane causes a decrease in membrane 
permeability and inhibits the binding of actin and other cytoplasmic proteins 
{Okimasu, Nobori, et al. 1987}. 
4.3.4 Effect of cell preincubation in conditions of insulin resistance on L6 
myotubes (TEM) 
TEM study was performed on cells preincubated in condition of insulin resistance 
including glucose and insulin, FFA or CHO. Unfortunately, due to the low 
antibodies staining in TEM, we cannot conclude a dose-dependent reduction similar 
to the IM study. Instead, unlike in the control cells where GLUT4myc colocalized 
with actin structures upon insulin stimulation (fig. 7), insulin failed to induce the 
translocation of GLUT4 with actin (fig. 10). The dissociation of actin and GLUT4 
supports our IM observations that pretreatment of cells in condition of insulin 
resistance reduces actin modeling and GLUT4 translocation. In the TEM study, 
most actin and GLUT4 stainings from insulin-stimulated cells preincubated in 
conditions of insulin resistance remained in their non insulin-stimulated location. 
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Given that glucose uptakes were also reduced, the TEM results confirmed the 
importance of GLUT4 translocation with actin in relation to glucose transport. 
4.4 Summary of the effects of cell preincubation in conditions of insulin 
resistance 
Taken together, the preincubation of cells in insulin resistant condition yields 
reductions in actin reorganization. By comparing with all three types of 
preincubations, the high glucose (25mM) and high insulin (lOOnM) incubation 
reduced the highest degree in actin reorganization, followed by LA, CHO, OA and PA. 
Surprisingly, the saturated FFA — PA produced the least effect on actin reorganization 
reduction despite of the adverse effect on saturated FFA on increasing blood CHO 
levels and CHD risk. 
Meanwhile, the obvious reduction in glucose uptake after incubation in conditions of 
insulin resistance was the combination of elevated basal values and suppressed 
insulin-stimulated glucose uptake values (table 9). The degree of increase in basal 
uptake was much greater than the insulin-stimulated state. Hence, the net effect was 
a reduction in glucose uptake following insulin stimulation. High glucose and high 
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insulin preincubation produced the highest reduction in glucose uptake followed by 
preincubation with unsaturated FFA and CHO. Finally, saturated PA incubation 
produced the least effect on glucose uptake reduction. Interestingly, there is a 
concordant in the reduction in glucose uptake and actin reorganization following 
preincubation of cells in conditions of insulin resistance. 
By comparing the data from insulin-mediated actin reorganization and glucose uptake, 
a striking conclusion can be made. The preincubation of cells in conditions of 
insulin resistance reduced both the actin reorganization and glucose uptake in a 
similar magnitude. The cell surface immunostaining also confirmed that there was a 
similar reduction of GLUT4 insertion on PM after the preincubation experiment. 
Furthermore, the colocalization of actin and GLUT4 was also abolished in the TEM 
study. Therefore, it is possible that a direct relationship between insulin-mediated 
actin reorganization and glucose uptake exists. There are previous studies supported 
our conclusion. An intact actin network is necessary for the exocytotic recruitment 
of GLUT4 {Omata, Shibata, et al. 2000}. Furthermore, actin disassembly has also 
been shown to cause reduction in glucose uptake {Tsakiridis, Vranic, et al. 1994}. In 
addition, insulin-stimulated GLUT4 appearance at the cell surface is reduced after 
Jasplakinolide treatment {Tong, Khayat, et al. 2001}. In the same study, 
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preincubation of high insulin and high glucose also diminishes glucose uptake and 
GLUT4 translocation. In fact, our results reconfirmed their findings. Therefore, it 
is conceivable that actin filaments may directly participate in controlling the GLUT4 
vesicle trafficking. Completed intact actin reorganization may play a critical role in 
insulin-mediated GLUT4 translocation and thereby control the glucose uptake. 
Several lines of evidences have shown the adverse effects of glucose, insulin, FFA and 
CHO preincubation in vivo on glucose metabolism. For example, high glucose 
perfusion in male Sprague-Dawley rats decreases both the glucose clearance rate and 
PM GLUT4 content {Mathoo, Shi, et al. 1999}. Meanwhile, elevated FFA levels 
caused by high fat diets in rats {Oakes, Cooney, et al. 1997} or triglyceride emulsion 
combined with heparin in humans {Roden, Price, et al. 1996} have been illustrated to 
decrease insulin-stimulated glucose transport. Indeed, our in vitro results confirmed 
these in vivo observations. 
4.5 Possible mechanisms involved in insulin resistance induction 
Given preincubating cells in conditions of insulin resistance abolishes both actin 
reorganization and GLUT4 translocation in L6 myotubes, several possible 
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mechanisms may be involved in the induction of insulin resistance: (1) Changes in 
GLUT expression and activities; (2) Changes in insulin signaling propagation; (3) 
Altered functioning of actin accessory proteins. 
4.5.1 Possible changes in GLUT expression and activities 
The effectiveness of glucose transport in muscle cells is largely depended on the 
expression and activities of GLUT. Preincubations with high glucose and insulin, 
elevated FFA or CHO caused an elevated basal glucose uptake out of proportion with 
the insulin-stimulated glucose uptake (table 9). Elevated basal uptake may be 
secondary to the mass-effect of high glucose concentration in the culture medium. 
Since GLUTl and GLUT3 are the primary GLUT at the basal state, insulin resistant 
preincubation in L6 myotubes may increase glucose uptake in basal state by 
increasing the GLUTl and GLUTS insertions on the PM. In fact, chronic insulin 
incubation has been observed to increase GLUTl and GLUTS protein expressions 
{Taha, Mitsumoto, et al. 1995}. On the other hand, GLUT4 is mainly responsible 
for the insulin-stimulated glucose uptake. High glucose incubation has been found 
to down-regulate GLUT4 translocation that leads to a reduction in muscle glucose 
uptake {Mathoo, Shi, et al. 1999}. In addition, elevated FFA inhibits glucose 
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transport in skeletal muscle probably through a decrease in GLUT-4 translocation 
{Shulman 2000}. Together with our own finding of decreased insulin-stimulated 
GLUT4 translocation, the decrease in GLUT4 insertion on PM may be responsible for 
the decrease in insulin-stimulated glucose uptake. Hence, the combination of 
increased expression in GLUTl and GLUT3, and the reduced translocation of GLUT4, 
may explain the induction of insulin resistance in L6 myotubes following high insulin 
and glucose preincuabtion. 
4.5.2 Possible changes in insulin signaling propagation 
Insulin signaling pathway is a multi-step pathway and requires numerous substrates 
and proteins to work in concert. Spatial arrangement and sequential phosphorylation 
of each intermediate are important for normal signal propagation. Study from 
Knutson has demonstrated that chronic insulin treatment results in an increased rate of 
IR degradation {Knutson, Donnelly et. 1995}. Furthermore, chronic insulin 
treatment has been reported to cause a reduction of IRS-1 and IRS-2 association with 
the cytoskeleton underlying the PM in 3T3-L1 fibroblasts {Clark, Molero, et al. 
2000}. Besides, OA and PA have been shown to decrease insulin binding without 
changing the receptor affinity {Svedberg, Bjomtorp, et al. 1990}. Taken together, 
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these results suggest that aberrant insulin signaling transudation may occur in cells 
maintained in high insulin or high fat conditions. The inhibitory effects can be 
additive causing derangement in actin reorganization and GLUT4 translocation. 
4.5.3 Altered functioning of various actin accessory proteins 
Our findings have demonstrated a reduction of actin remodeling in the preincubation 
experiments. It is plausible that the preincubation may influence the functioning of 
actin accessory proteins and cause aberrant actin remodeling. Previous study has 
been shown that unsaturated FFA alters the normal distribution pattern of spectrin 
organization {Stephen, Yokota, et al. 1990}. In addition, lipid-specific differences 
in bindings between FFA to cytoskeletal structures and a-actinin have been 
established {Burn 1988}. PA incubation shows a six time higher labeling than those 
in AA incubation. Furthermore, chronic CHO incubation has been demonstrated to 
alter the organization of actin filament in human renal carcinoma cells {Ludes, Schmit, 
et al. 1993}. Introduction of CHO into liposomal membrane inhibits the binding of 
actin and other cytoplasmic proteins (Okimasu, Nobori, et al. 1987). Hence, by 
interfering the functioning of actin accessory proteins, preincubations may affect the 
insulin-mediated actin remodeling and thereby reduce glucose uptake. 
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4.6 Limitation of the study 
There are several limitations in our study. First of all, L6 skeletal cell is an in vitro 
cell line model and may not truly be representative in in vivo situation. Secondly, L6 
myotubes were separately preincubated in FFA, CHO or glucose and insulin in our 
experiments. However, in in vivo situation, the body may be constantly influenced 
by a combination of conditions of insulin resistance and the resulting effects may be 
different from our own findings. Thirdly, the introduction of agents mimicking the 
conditions of insulin resistance may be different between in vivo and in vitro 
situations. For example, free CHO and FFA were introduced to the cell culture while 
in human body CHO and FFA bind to carrier molecules. Thus, our experimental 
results may not be directly related to the in vivo situation, as the artificial conditions 
created in our studies may not reflect the true cellular environment in diabetes. 
Further studies are therefore required to overcome these limitations. 
4.7 Conclusion 
In conclusion, insulin stimulates glucose transport in skeletal muscle cells by inducing 
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actin reorganization and GLUT4 translocation. The results of TEM provide 
concreted evidence on the colocalization of actin and GLUT4 at an ultra-structural 
level. Hyperglycemia and hyperinsulinemia are common in patients with diabetes. 
They usually have higher plasma FFA and total serum CHO levels than normal 
subjects. Thus, these metabolic derangements act synergistically to exacerbate 
insulin resistance in patients with Type II diabetes. Preincubation of cells in the 
conditions of insulin resistance creates a form of resistance to insulin treatment by 
suppressing actin reorganization and abolishing glucose uptake. Importantly, the 
novel knowledge of actin reorganization and glucose uptake suppression by FFA and 
CHO preincubations provides new sight on cellular mechanism of insulin resistance. 
4.8 Future study 
The experimental findings of the present study demonstrated reductions of actin 
remodeling and glucose uptake following preincubation of L6 myotubes in conditions 
of insulin resistance. The aberrant actin remodeling and glucose uptake may be 
resulted from the changes in GLUT expression and activities, changes in insulin 
signal propagation and interference of the functioning of various actin accessory 
proteins. To understand how these are attained will be an important challenge for 
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the future. Future studies will be aimed at identifying the exact intermediates 
involved in abnormal mechanisms. For instance, we can identify the activities of 
different insulin signaling molecules before and after preincubation. Besides, the 
investigation of GLUTl, GLUTS and GLUT4 expression and activities also allow us 
to elucidate the effect of GLUT on glucose transport. Furthermore, transient 
transfection of various insulin signaling molecules or actin accessory proteins 
involved in actin remodeling may provide further insights of the basis of insulin 
resistance. Finally, this study demonstrates that L6 myotubes is a good in vitro 
cellular model for the investigation of insulin resistance. Hence, the use of L6 
myotubes may allow us to screen for pharmacological agents that are effective in the 
management of insulin resistance and related conditions. 
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